{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:39:18Z","timestamp":1794353958316,"version":"4.9.0"},"reference-count":400,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05263-z","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T10:00:31Z","timestamp":1755338431000},"page":"16512-16556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?"],"prefix":"10.1007","volume":"62","author":[{"given":"Ashi","family":"Mannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"5263_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101897","volume":"41","author":"M\u0391 Vasilopoulou","year":"2021","unstructured":"Vasilopoulou M\u0391, Ioannou E, Roussis V, Chondrogianni N (2021) Modulation of the ubiquitin-proteasome system by marine natural products. Redox Biology 41:101897. https:\/\/doi.org\/10.1016\/j.redox.2021.101897","journal-title":"Redox Biology"},{"key":"5263_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.585309","volume":"7","author":"N Kaur","year":"2020","unstructured":"Kaur N, Raja R, Ruiz-Velasco A, Liu W (2020) Cellular protein quality control in diabetic cardiomyopathy: from bench to bedside. Front Cardiovasc Med 7:585309. https:\/\/doi.org\/10.3389\/fcvm.2020.585309","journal-title":"Front Cardiovasc Med"},{"key":"5263_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111971","volume":"22","author":"A Sharma","year":"2021","unstructured":"Sharma A, Khan H, Singh TG et al (2021) Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling. Int J Mol Sci 22:11971. https:\/\/doi.org\/10.3390\/ijms222111971","journal-title":"Int J Mol Sci"},{"key":"5263_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-35775-3.00001-1","volume":"2\u201343","author":"MA Miller","year":"2017","unstructured":"Miller MA, Zachary JF (2017) Mechanisms and morphology of cellular injury, adaptation, and death. Pathol Basis Vet Dis 2\u201343:e19. https:\/\/doi.org\/10.1016\/B978-0-323-35775-3.00001-1","journal-title":"Pathol Basis Vet Dis"},{"key":"5263_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbagrm.2010.07.005","volume":"1809","author":"N Livnat-Levanon","year":"2011","unstructured":"Livnat-Levanon N, Glickman MH (2011) Ubiquitin-proteasome system and mitochondria - reciprocity. Biochim Biophys Acta 1809:80\u201387. https:\/\/doi.org\/10.1016\/j.bbagrm.2010.07.005","journal-title":"Biochim Biophys Acta"},{"key":"5263_CR6","doi-asserted-by":"publisher","first-page":"19601","DOI":"10.1007\/s11356-021-12781-5","volume":"28","author":"A Gupta","year":"2021","unstructured":"Gupta A, Behl T, Aleya L et al (2021) Role of UPP pathway in amelioration of diabetes-associated complications. Environ Sci Pollut Res Int 28:19601\u201319614. https:\/\/doi.org\/10.1007\/s11356-021-12781-5","journal-title":"Environ Sci Pollut Res Int"},{"key":"5263_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1517\/14728222.2013.815728","volume":"17","author":"M Shen","year":"2013","unstructured":"Shen M, Schmitt S, Buac D, Dou QP (2013) Targeting the ubiquitin-proteasome system for cancer therapy. Expert Opin Ther Targets 17:1091\u20131108. https:\/\/doi.org\/10.1517\/14728222.2013.815728","journal-title":"Expert Opin Ther Targets"},{"key":"5263_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.conb.2005.08.016","volume":"15","author":"B Bingol","year":"2005","unstructured":"Bingol B, Schuman EM (2005) Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 15:536\u2013541. https:\/\/doi.org\/10.1016\/j.conb.2005.08.016","journal-title":"Curr Opin Neurobiol"},{"key":"5263_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00070","volume":"7","author":"NP Dantuma","year":"2014","unstructured":"Dantuma NP, Bott LC (2014) The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci 7:70. https:\/\/doi.org\/10.3389\/fnmol.2014.00070","journal-title":"Front Mol Neurosci"},{"key":"5263_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1248\/bpb.33.1953","volume":"33","author":"AK Rehni","year":"2010","unstructured":"Rehni AK, Singh TG, Behl N, Arora S (2010) Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice. Biol Pharm Bull 33:1953\u20131957. https:\/\/doi.org\/10.1248\/bpb.33.1953","journal-title":"Biol Pharm Bull"},{"key":"5263_CR11","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1073\/pnas.1504161112","volume":"112","author":"NG Brown","year":"2015","unstructured":"Brown NG, VanderLinden R, Watson ER et al (2015) RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex. Proc Natl Acad Sci 112:5272\u20135279. https:\/\/doi.org\/10.1073\/pnas.1504161112","journal-title":"Proc Natl Acad Sci"},{"key":"5263_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrm2673","volume":"10","author":"BA Schulman","year":"2009","unstructured":"Schulman BA, Wade Harper J (2009) Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 10:319\u2013331. https:\/\/doi.org\/10.1038\/nrm2673","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5263_CR13","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1007\/s12035-022-03042-8","volume":"59","author":"G Chopra","year":"2022","unstructured":"Chopra G, Shabir S, Yousuf S et al (2022) Proteinopathies: deciphering physiology and mechanisms to develop effective therapies for neurodegenerative diseases. Mol Neurobiol 59:7513\u20137540. https:\/\/doi.org\/10.1007\/s12035-022-03042-8","journal-title":"Mol Neurobiol"},{"key":"5263_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042361","volume":"25","author":"S Magnati","year":"2024","unstructured":"Magnati S, Alladio E, Bracco E (2024) A survey on the expression of the ubiquitin proteasome system components HECT- and RBR-E3 ubiquitin ligases and E2 ubiquitin-conjugating and E1 ubiquitin-activating enzymes during human brain development. Int J Mol Sci 25:2361. https:\/\/doi.org\/10.3390\/ijms25042361","journal-title":"Int J Mol Sci"},{"key":"5263_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0092-8674(00)80574-7","volume":"96","author":"M Koegl","year":"1999","unstructured":"Koegl M, Hoppe T, Schlenker S et al (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96:635\u2013644. https:\/\/doi.org\/10.1016\/S0092-8674(00)80574-7","journal-title":"Cell"},{"key":"5263_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41380-021-01233-8","volume":"27","author":"B Liu","year":"2022","unstructured":"Liu B, Ruan J, Chen M et al (2022) Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases. Mol Psychiatry 27:259\u2013268. https:\/\/doi.org\/10.1038\/s41380-021-01233-8","journal-title":"Mol Psychiatry"},{"key":"5263_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2022.104592","volume":"262","author":"L van der Wal","year":"2022","unstructured":"van der Wal L, Bezstarosti K, Demmers JAA (2022) A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37. J Proteomics 262:104592. https:\/\/doi.org\/10.1016\/j.jprot.2022.104592","journal-title":"J Proteomics"},{"key":"5263_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41420-024-02237-3","volume":"10","author":"B Qin","year":"2024","unstructured":"Qin B, Chen X, Wang F, Wang Y (2024) DUBs in Alzheimer\u2019s disease: mechanisms and therapeutic implications. Cell Death Discov 10:475. https:\/\/doi.org\/10.1038\/s41420-024-02237-3","journal-title":"Cell Death Discov"},{"key":"5263_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.977411","volume":"14","author":"I Mumtaz","year":"2022","unstructured":"Mumtaz I, Ayaz MO, Khan MS et al (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci 14:977411. https:\/\/doi.org\/10.3389\/fnagi.2022.977411","journal-title":"Front Aging Neurosci"},{"key":"5263_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nrn2499","volume":"9","author":"H-C Tai","year":"2008","unstructured":"Tai H-C, Schuman EM (2008) Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9:826\u2013838. https:\/\/doi.org\/10.1038\/nrn2499","journal-title":"Nat Rev Neurosci"},{"key":"5263_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s40478-022-01465-x","volume":"10","author":"K Vijayaragavan","year":"2022","unstructured":"Vijayaragavan K, Cannon BJ, Tebaykin D et al (2022) Single-cell spatial proteomic imaging for human neuropathology. Acta Neuropathol Commun 10:158. https:\/\/doi.org\/10.1186\/s40478-022-01465-x","journal-title":"Acta Neuropathol Commun"},{"key":"5263_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.711446","volume":"9","author":"D Rajgor","year":"2021","unstructured":"Rajgor D, Welle TM, Smith KR (2021) The coordination of local translation, membranous organelle trafficking, and synaptic plasticity in neurons. Front Cell Dev Biol 9:711446. https:\/\/doi.org\/10.3389\/fcell.2021.711446","journal-title":"Front Cell Dev Biol"},{"key":"5263_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00361","volume":"11","author":"S Momtaz","year":"2020","unstructured":"Momtaz S, Memariani Z, El-Senduny FF et al (2020) Targeting ubiquitin-proteasome pathway by natural products: novel therapeutic strategy for treatment of neurodegenerative diseases. Front Physiol 11:361. https:\/\/doi.org\/10.3389\/fphys.2020.00361","journal-title":"Front Physiol"},{"key":"5263_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J et al (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther 9:211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Sig Transduct Target Ther"},{"key":"5263_CR25","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1039\/D3CS00344B","volume":"53","author":"J Kim","year":"2024","unstructured":"Kim J, Byun I, Young Kim D et al (2024) Targeted protein degradation directly engaging lysosomes or proteasomes. Chem Soc Rev 53:3253\u20133272. https:\/\/doi.org\/10.1039\/D3CS00344B","journal-title":"Chem Soc Rev"},{"key":"5263_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/life11070607","volume":"11","author":"S Hyun","year":"2021","unstructured":"Hyun S, Shin D (2021) Chemical-mediated targeted protein degradation in neurodegenerative diseases. Life 11:607. https:\/\/doi.org\/10.3390\/life11070607","journal-title":"Life"},{"key":"5263_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.768655","volume":"15","author":"FM Potjewyd","year":"2021","unstructured":"Potjewyd FM, Axtman AD (2021) Exploration of aberrant E3 ligases implicated in Alzheimer\u2019s disease and development of chemical tools to modulate their function. Front Cell Neurosci 15:768655. https:\/\/doi.org\/10.3389\/fncel.2021.768655","journal-title":"Front Cell Neurosci"},{"key":"5263_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12640-020-00185-1","volume":"38","author":"A Al Mamun","year":"2020","unstructured":"Al Mamun A, Uddin MdS, Kabir MdT et al (2020) Exploring the promise of targeting ubiquitin-proteasome system to combat Alzheimer\u2019s disease. Neurotox Res 38:8\u201317. https:\/\/doi.org\/10.1007\/s12640-020-00185-1","journal-title":"Neurotox Res"},{"key":"5263_CR29","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/mds.29058","volume":"37","author":"S Engelender","year":"2022","unstructured":"Engelender S, Stefanis L, Oddo S, Bellucci A (2022) Can we treat neurodegenerative proteinopathies by enhancing protein degradation? Mov Disord 37:1346\u20131359. https:\/\/doi.org\/10.1002\/mds.29058","journal-title":"Mov Disord"},{"key":"5263_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2018.11","volume":"39","author":"RJ Harding","year":"2018","unstructured":"Harding RJ, Tong Y (2018) Proteostasis in Huntington\u2019s disease: disease mechanisms and therapeutic opportunities. Acta Pharmacol Sin 39:754\u2013769. https:\/\/doi.org\/10.1038\/aps.2018.11","journal-title":"Acta Pharmacol Sin"},{"key":"5263_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00123","volume":"10","author":"CP Webster","year":"2017","unstructured":"Webster CP, Smith EF, Shaw PJ, De Vos KJ (2017) Protein homeostasis in amyotrophic lateral sclerosis: therapeutic opportunities? Front Mol Neurosci 10:123. https:\/\/doi.org\/10.3389\/fnmol.2017.00123","journal-title":"Front Mol Neurosci"},{"key":"5263_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.733012","volume":"14","author":"F Ebstein","year":"2021","unstructured":"Ebstein F, K\u00fcry S, Papendorf JJ, Kr\u00fcger E (2021) Neurodevelopmental disorders (NDD) caused by genomic alterations of the ubiquitin-proteasome system (UPS): the possible contribution of immune dysregulation to disease pathogenesis. Front Mol Neurosci 14:733012. https:\/\/doi.org\/10.3389\/fnmol.2021.733012","journal-title":"Front Mol Neurosci"},{"key":"5263_CR33","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1089\/ars.2013.5802","volume":"21","author":"C McKinnon","year":"2014","unstructured":"McKinnon C, Tabrizi SJ (2014) The ubiquitin-proteasome system in neurodegeneration. Antioxid Redox Signal 21:2302\u20132321. https:\/\/doi.org\/10.1089\/ars.2013.5802","journal-title":"Antioxid Redox Signal"},{"issue":"Pt 2","key":"5263_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/brain\/114.2.775","volume":"114","author":"PN Leigh","year":"1991","unstructured":"Leigh PN, Whitwell H, Garofalo O et al (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114(Pt 2):775\u2013788. https:\/\/doi.org\/10.1093\/brain\/114.2.775","journal-title":"Brain"},{"key":"5263_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"5263_CR36","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399411002031","volume":"13","author":"MJ Edelmann","year":"2011","unstructured":"Edelmann MJ, Nicholson B, Kessler BM (2011) Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert Rev Mol Med 13:e35. https:\/\/doi.org\/10.1017\/S1462399411002031","journal-title":"Expert Rev Mol Med"},{"key":"5263_CR37","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk ASF, Lundgaard I, Nedergaard M (2015) The glymphatic system: a beginner\u2019s guide. Neurochem Res 40:2583\u20132599. https:\/\/doi.org\/10.1007\/s11064-015-1581-6","journal-title":"Neurochem Res"},{"key":"5263_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI67677","volume":"123","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Lee H, Yu M et al (2013) Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 123:1299\u20131309. https:\/\/doi.org\/10.1172\/JCI67677","journal-title":"J Clin Invest"},{"key":"5263_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2004.12.004","volume":"27","author":"M Mishto","year":"2006","unstructured":"Mishto M, Bellavista E, Santoro A et al (2006) Immunoproteasome and LMP2 polymorphism in aged and Alzheimer\u2019s disease brains. Neurobiol Aging 27:54\u201366. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.12.004","journal-title":"Neurobiol Aging"},{"key":"5263_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuropharm.2013.08.034","volume":"76","author":"M Halliday","year":"2014","unstructured":"Halliday M, Mallucci GR (2014) Targeting the unfolded protein response in neurodegeneration: a new approach to therapy. Neuropharmacology 76:169\u2013174. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.034","journal-title":"Neuropharmacology"},{"key":"5263_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4149\/gpb_2015024","volume":"34","author":"A Opattova","year":"2015","unstructured":"Opattova A, Cente M, Novak M, Filipcik P (2015) The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases. Gen Physiol Biophys 34:337\u2013352. https:\/\/doi.org\/10.4149\/gpb_2015024","journal-title":"Gen Physiol Biophys"},{"key":"5263_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031413","volume":"22","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur G, Sehgal A et al (2021) Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives. Int J Mol Sci 22:1413. https:\/\/doi.org\/10.3390\/ijms22031413","journal-title":"Int J Mol Sci"},{"key":"5263_CR43","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11064-023-03873-4","volume":"48","author":"VK Sharma","year":"2023","unstructured":"Sharma VK, Singh TG, Mehta V, Mannan A (2023) Biomarkers: role and scope in neurological disorders. Neurochem Res 48:2029\u20132058. https:\/\/doi.org\/10.1007\/s11064-023-03873-4","journal-title":"Neurochem Res"},{"key":"5263_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1179\/1743132813Y.0000000288","volume":"36","author":"L Hong","year":"2014","unstructured":"Hong L, Huang H-C, Jiang Z-F (2014) Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease. Neurol Res 36:276\u2013282. https:\/\/doi.org\/10.1179\/1743132813Y.0000000288","journal-title":"Neurol Res"},{"key":"5263_CR45","doi-asserted-by":"publisher","first-page":"E15743624267214","DOI":"10.2174\/0115743624267214241016103515","volume":"20","author":"A Sharma","year":"2025","unstructured":"Sharma A, Devi S, Mannan A et al (2025) PPAR-\u03b3 signaling and common protective pathways against obesity and Alzheimer\u2019s disease. Curr Signal Transduct Ther 20:E15743624267214. https:\/\/doi.org\/10.2174\/0115743624267214241016103515","journal-title":"Curr Signal Transduct Ther"},{"key":"5263_CR46","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4161\/auto.21011","volume":"8","author":"B Dehay","year":"2012","unstructured":"Dehay B, Martinez-Vicente M, Ramirez A et al (2012) Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8:1389\u20131391. https:\/\/doi.org\/10.4161\/auto.21011","journal-title":"Autophagy"},{"key":"5263_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05153-5","volume":"13","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Lindholm D, Ren J, Pratico D (2022) ER stress and UPR in Alzheimer\u2019s disease: mechanisms, pathogenesis, treatments. Cell Death Dis 13:1\u201315. https:\/\/doi.org\/10.1038\/s41419-022-05153-5","journal-title":"Cell Death Dis"},{"key":"5263_CR48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12035-014-9063-4","volume":"53","author":"YA Sulistio","year":"2016","unstructured":"Sulistio YA, Heese K (2016) The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer\u2019s disease. Mol Neurobiol 53:905\u2013931. https:\/\/doi.org\/10.1007\/s12035-014-9063-4","journal-title":"Mol Neurobiol"},{"key":"5263_CR49","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s12035-022-03164-z","volume":"60","author":"P Kaur","year":"2023","unstructured":"Kaur P, Khera A, Alajangi HK et al (2023) Role of Tau in various tauopathies, treatment approaches, and emerging role of nanotechnology in neurodegenerative disorders. Mol Neurobiol 60:1690\u20131720. https:\/\/doi.org\/10.1007\/s12035-022-03164-z","journal-title":"Mol Neurobiol"},{"key":"5263_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1258\/ebm.2010.010327","volume":"236","author":"BM Riederer","year":"2011","unstructured":"Riederer BM, Leuba G, Vernay A, Riederer IM (2011) The role of the ubiquitin proteasome system in Alzheimer\u2019s disease. Exp Biol Med (Maywood) 236:268\u2013276. https:\/\/doi.org\/10.1258\/ebm.2010.010327","journal-title":"Exp Biol Med (Maywood)"},{"key":"5263_CR51","doi-asserted-by":"publisher","first-page":"194936","DOI":"10.1016\/j.bbagrm.2023.194936","volume":"1866","author":"AR Wagh","year":"2023","unstructured":"Wagh AR, Sulakshane P, Glickman MH (2023) Alzheimer\u2019s disease-associated mutant ubiquitin (UBB+1) is secreted through an autophagosome-like vesicle-mediated unconventional pathway. Biochim et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1866:194936. https:\/\/doi.org\/10.1016\/j.bbagrm.2023.194936","journal-title":"Biochim et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"5263_CR52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.279.5348.242","volume":"279","author":"FW van Leeuwen","year":"1998","unstructured":"van Leeuwen FW, de Kleijn DP, van den Hurk HH et al (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer\u2019s and Down patients. Science 279:242\u2013247. https:\/\/doi.org\/10.1126\/science.279.5348.242","journal-title":"Science"},{"key":"5263_CR53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","volume":"12","author":"S Oddo","year":"2008","unstructured":"Oddo S (2008) The ubiquitin-proteasome system in Alzheimer\u2019s disease. J Cell Mol Med 12:363\u2013373. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00276.x","journal-title":"J Cell Mol Med"},{"key":"5263_CR54","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/jcmm.12817","volume":"20","author":"K Gadhave","year":"2016","unstructured":"Gadhave K, Bolshette N, Ahire A et al (2016) The ubiquitin proteasomal system: a potential target for the management of Alzheimer\u2019s disease. J Cell Mol Med 20:1392\u20131407. https:\/\/doi.org\/10.1111\/jcmm.12817","journal-title":"J Cell Mol Med"},{"key":"5263_CR55","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/cbic.201900573","volume":"21","author":"M Ramesh","year":"2020","unstructured":"Ramesh M, Gopinath P, Govindaraju T (2020) Role of post-translational modifications in Alzheimer\u2019s disease. ChemBioChem 21:1052\u20131079. https:\/\/doi.org\/10.1002\/cbic.201900573","journal-title":"ChemBioChem"},{"key":"5263_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11011-025-01623-9","volume":"40","author":"A Sharma","year":"2025","unstructured":"Sharma A, Mannan A, Singh S, Singh TG (2025) A second act for spironolactone: cognitive benefits in renal dysfunction \u2013 a critical review. Metab Brain Dis 40:194. https:\/\/doi.org\/10.1007\/s11011-025-01623-9","journal-title":"Metab Brain Dis"},{"key":"5263_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04739-2","author":"F Jia","year":"2025","unstructured":"Jia F, Fu L (2025) Roles of ubiquitin ligases and deubiquitylases in Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04739-2","journal-title":"Mol Neurobiol"},{"key":"5263_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101078","volume":"61","author":"D Kumar","year":"2020","unstructured":"Kumar D, Ambasta RK, Kumar P (2020) Ubiquitin biology in neurodegenerative disorders: from impairment to therapeutic strategies. Ageing Res Rev 61:101078. https:\/\/doi.org\/10.1016\/j.arr.2020.101078","journal-title":"Ageing Res Rev"},{"key":"5263_CR59","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem 75:436\u2013439. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0750436.x","journal-title":"J Neurochem"},{"key":"5263_CR60","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ptr.5095","volume":"28","author":"C Scuderi","year":"2014","unstructured":"Scuderi C, Steardo L, Esposito G (2014) Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement. Phytother Res 28:1007\u20131013. https:\/\/doi.org\/10.1002\/ptr.5095","journal-title":"Phytother Res"},{"key":"5263_CR61","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.jafc.9b07022","volume":"68","author":"N Cai","year":"2020","unstructured":"Cai N, Chen J, Bi D et al (2020) Specific degradation of endogenous Tau protein and inhibition of Tau fibrillation by tanshinone IIA through the ubiquitin-proteasome pathway. J Agric Food Chem 68:2054\u20132062. https:\/\/doi.org\/10.1021\/acs.jafc.9b07022","journal-title":"J Agric Food Chem"},{"key":"5263_CR62","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides. J Biol Chem 280:37377\u201337382. https:\/\/doi.org\/10.1074\/jbc.M508246200","journal-title":"J Biol Chem"},{"key":"5263_CR63","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1016\/j.febslet.2007.09.031","volume":"581","author":"L Huang","year":"2007","unstructured":"Huang L, Ho P, Chen C-H (2007) Activation and inhibition of the proteasome by betulinic acid and its derivatives. FEBS Lett 581:4955\u20134959. https:\/\/doi.org\/10.1016\/j.febslet.2007.09.031","journal-title":"FEBS Lett"},{"key":"5263_CR64","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","volume":"23","author":"T-T Chu","year":"2016","unstructured":"Chu T-T, Gao N, Li Q-Q et al (2016) Specific knockdown of endogenous Tau protein by peptide-directed ubiquitin-proteasome degradation. Cell Chem Biol 23:453\u2013461. https:\/\/doi.org\/10.1016\/j.chembiol.2016.02.016","journal-title":"Cell Chem Biol"},{"key":"5263_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1379\/1466-1268(2001)006<0105:gtpoac>2.0.co;2","volume":"6","author":"HJ Ochel","year":"2001","unstructured":"Ochel HJ, Eichhorn K, Gademann G (2001) Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Cell Stress Chaperones 6:105\u2013112. https:\/\/doi.org\/10.1379\/1466-1268(2001)006%3c0105:gtpoac%3e2.0.co;2","journal-title":"Cell Stress Chaperones"},{"key":"5263_CR66","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/JAD-2012-121072","volume":"33","author":"A Opattova","year":"2013","unstructured":"Opattova A, Filipcik P, Cente M, Novak M (2013) Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome. J Alzheimers Dis 33:339\u2013348. https:\/\/doi.org\/10.3233\/JAD-2012-121072","journal-title":"J Alzheimers Dis"},{"key":"5263_CR67","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.7150\/thno.55680","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Zhou Q, Jiang T et al (2021) A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models. Theranostics 11:5279\u20135295. https:\/\/doi.org\/10.7150\/thno.55680","journal-title":"Theranostics"},{"key":"5263_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","volume":"146","author":"M Lu","year":"2018","unstructured":"Lu M, Liu T, Jiao Q et al (2018) Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway. Eur J Med Chem 146:251\u2013259. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.063","journal-title":"Eur J Med Chem"},{"key":"5263_CR69","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1074\/jbc.M305838200","volume":"279","author":"H Shimura","year":"2004","unstructured":"Shimura H, Schwartz D, Gygi SP, Kosik KS (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279:4869\u20134876. https:\/\/doi.org\/10.1074\/jbc.M305838200","journal-title":"J Biol Chem"},{"key":"5263_CR70","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.bbadis.2014.05.029","volume":"1842","author":"K Flach","year":"2014","unstructured":"Flach K, Ramminger E, Hilbrich I et al (2014) Axotrophin\/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding. Biochim Biophys Acta 1842:1527\u20131538. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.029","journal-title":"Biochim Biophys Acta"},{"key":"5263_CR71","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Liu F, Gong C-X, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7:656\u2013664","journal-title":"Curr Alzheimer Res"},{"key":"5263_CR72","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JAD-190635","volume":"72","author":"X Liu","year":"2019","unstructured":"Liu X, Hebron ML, Mulki S et al (2019) Ubiquitin specific protease 13 regulates Tau accumulation and clearance in models of Alzheimer\u2019s disease. J Alzheimers Dis 72:425\u2013441. https:\/\/doi.org\/10.3233\/JAD-190635","journal-title":"J Alzheimers Dis"},{"key":"5263_CR73","doi-asserted-by":"publisher","first-page":"069","DOI":"10.7324\/JAPS.2024.162341","volume":"14","author":"TG Singh","year":"2024","unstructured":"Singh TG, Sharma A, Devi S (2024) Exploring the mechanisms of chrysin in combating Alzheimer\u2019s disease: therapeutic perspectives. J App Pharm Sci 14:069\u2013078. https:\/\/doi.org\/10.7324\/JAPS.2024.162341","journal-title":"J App Pharm Sci"},{"key":"5263_CR74","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1517\/14728222.2014.943185","volume":"18","author":"LJ Blair","year":"2014","unstructured":"Blair LJ, Sabbagh JJ, Dickey CA (2014) Targeting Hsp90 and its co-chaperones to treat Alzheimer\u2019s disease. Expert Opin Ther Targets 18:1219\u20131232. https:\/\/doi.org\/10.1517\/14728222.2014.943185","journal-title":"Expert Opin Ther Targets"},{"key":"5263_CR75","first-page":"43","volume":"2","author":"UK Jinwal","year":"2010","unstructured":"Jinwal UK, Koren J, O\u2019Leary JC et al (2010) Hsp70 ATPase modulators as therapeutics for Alzheimer\u2019s and other neurodegenerative diseases. Mol Cell Pharmacol 2:43\u201346","journal-title":"Mol Cell Pharmacol"},{"key":"5263_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2024.100579","volume":"54","author":"N Garg","year":"2025","unstructured":"Garg N, Mannan A, Mohan M, Singh TG (2025) Therapeutic efficacy of hydroalcoholic extract of Euphorbia prostrata Aiton in NAD-STZ-induced diabetic nephropathy: a multifaceted intervention targeting oxidative stress and inflammation. Obesity Medicine 54:100579. https:\/\/doi.org\/10.1016\/j.obmed.2024.100579","journal-title":"Obesity Medicine"},{"key":"5263_CR77","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.chembiol.2017.05.010","volume":"24","author":"Y Leestemaker","year":"2017","unstructured":"Leestemaker Y, de Jong A, Witting KF et al (2017) Proteasome activation by small molecules. Cell Chem Biol 24:725-736.e7. https:\/\/doi.org\/10.1016\/j.chembiol.2017.05.010","journal-title":"Cell Chem Biol"},{"key":"5263_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170959","volume":"63","author":"JP Quinn","year":"2018","unstructured":"Quinn JP, Corbett NJ, Kellett KAB, Hooper NM (2018) Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers. Journal of Alzheimer\u2019s Disease 63:13\u201333. https:\/\/doi.org\/10.3233\/JAD-170959","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"5263_CR79","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.molcel.2003.08.005","volume":"12","author":"S Song","year":"2003","unstructured":"Song S, Kim S-Y, Hong Y-M et al (2003) Essential role of E2\u201325K\/Hip-2 in mediating amyloid-\u03b2 neurotoxicity. Mol Cell 12:553\u2013563. https:\/\/doi.org\/10.1016\/j.molcel.2003.08.005","journal-title":"Mol Cell"},{"key":"5263_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-00930-2","volume":"10","author":"X Jian","year":"2020","unstructured":"Jian X, Sofer T, Tarraf W et al (2020) Genome-wide association study of cognitive function in diverse Hispanics\/Latinos: results from the Hispanic Community Health Study\/Study of Latinos. Transl Psychiatry 10:1\u201313. https:\/\/doi.org\/10.1038\/s41398-020-00930-2","journal-title":"Transl Psychiatry"},{"key":"5263_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/genes12121959","volume":"12","author":"R Rabaneda-Bueno","year":"2021","unstructured":"Rabaneda-Bueno R, Mena-Montes B, Torres-Castro S et al (2021) Advances in genetics and epigenetic alterations in Alzheimer\u2019s disease: a notion for therapeutic treatment. Genes 12:1959. https:\/\/doi.org\/10.3390\/genes12121959","journal-title":"Genes"},{"key":"5263_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/256404","volume":"2013","author":"CMF Pereira","year":"2013","unstructured":"Pereira CMF (2013) Crosstalk between endoplasmic reticulum stress and protein misfolding in neurodegenerative diseases. International Scholarly Research Notices 2013:256404. https:\/\/doi.org\/10.1155\/2013\/256404","journal-title":"International Scholarly Research Notices"},{"key":"5263_CR83","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molmed.2004.09.005","volume":"10","author":"S Song","year":"2004","unstructured":"Song S, Jung Y-K (2004) Alzheimer\u2019s disease meets the ubiquitin\u2013proteasome system. Trends Mol Med 10:565\u2013570. https:\/\/doi.org\/10.1016\/j.molmed.2004.09.005","journal-title":"Trends Mol Med"},{"key":"5263_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010040","volume":"8","author":"K Zientara-Rytter","year":"2019","unstructured":"Zientara-Rytter K, Subramani S (2019) The roles of ubiquitin-binding protein shuttles in the degradative fate of ubiquitinated proteins in the ubiquitin-proteasome system and autophagy. Cells 8:40. https:\/\/doi.org\/10.3390\/cells8010040","journal-title":"Cells"},{"key":"5263_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00126","volume":"12","author":"HA Bustamante","year":"2018","unstructured":"Bustamante HA, Gonz\u00e1lez AE, Cerda-Troncoso C et al (2018) Interplay between the autophagy-lysosomal pathway and the ubiquitin-proteasome system: a target for therapeutic development in Alzheimer\u2019s disease. Front Cell Neurosci 12:126. https:\/\/doi.org\/10.3389\/fncel.2018.00126","journal-title":"Front Cell Neurosci"},{"key":"5263_CR86","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molmed.2019.05.008","volume":"25","author":"K Hnia","year":"2019","unstructured":"Hnia K, Clausen T, Moog-Lutz C (2019) Shaping striated muscles with ubiquitin proteasome system in health and disease. Trends Mol Med 25:760\u2013774. https:\/\/doi.org\/10.1016\/j.molmed.2019.05.008","journal-title":"Trends Mol Med"},{"key":"5263_CR87","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.mp.4001775","volume":"11","author":"MI Kamboh","year":"2006","unstructured":"Kamboh MI, Minster RL, Feingold E, DeKosky ST (2006) Genetic association of ubiquilin with Alzheimer\u2019s disease and related quantitative measures. Mol Psychiatry 11:273\u2013279. https:\/\/doi.org\/10.1038\/sj.mp.4001775","journal-title":"Mol Psychiatry"},{"key":"5263_CR88","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11011-025-01642-6","volume":"40","author":"A Sharma","year":"2025","unstructured":"Sharma A, Mannan A, Singh TG (2025) Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin resistance-induced amyloidogenesis. Metab Brain Dis 40:218. https:\/\/doi.org\/10.1007\/s11011-025-01642-6","journal-title":"Metab Brain Dis"},{"key":"5263_CR89","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1007\/s12035-018-0955-6","volume":"55","author":"K V\u00f6lgyi","year":"2018","unstructured":"V\u00f6lgyi K, Badics K, Sialana FJ et al (2018) Early presymptomatic changes in the proteome of mitochondria-associated membrane in the APP\/PS1 mouse model of Alzheimer\u2019s disease. Mol Neurobiol 55:7839\u20137857. https:\/\/doi.org\/10.1007\/s12035-018-0955-6","journal-title":"Mol Neurobiol"},{"key":"5263_CR90","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1517\/14728222.2013.791284","volume":"17","author":"M Takalo","year":"2013","unstructured":"Takalo M, Haapasalo A, Natunen T et al (2013) Targeting ubiquilin-1 in Alzheimer\u2019s disease. Expert Opin Ther Targets 17:795\u2013810. https:\/\/doi.org\/10.1517\/14728222.2013.791284","journal-title":"Expert Opin Ther Targets"},{"key":"5263_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnmol.2015.00047","volume":"8","author":"RJ Gentier","year":"2015","unstructured":"Gentier RJ, van Leeuwen FW (2015) Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer\u2019s disease. Front Mol Neurosci 8:47. https:\/\/doi.org\/10.3389\/fnmol.2015.00047","journal-title":"Front Mol Neurosci"},{"key":"5263_CR92","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/156720512800492440","volume":"9","author":"X Elcoroaristizabal Martin","year":"2012","unstructured":"Elcoroaristizabal Martin X, Fernandez Martinez M, Gamarra Fernandez D et al (2012) UBQ-8i Polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer\u2019s disease in APOE-4 carriers. Curr Alzheimer Res 9:467\u2013472. https:\/\/doi.org\/10.2174\/156720512800492440","journal-title":"Curr Alzheimer Res"},{"key":"5263_CR93","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40263-019-00657-9","volume":"33","author":"L McAlary","year":"2019","unstructured":"McAlary L, Plotkin SS, Cashman NR (2019) Emerging developments in targeting proteotoxicity in neurodegenerative diseases. CNS Drugs 33:883\u2013904. https:\/\/doi.org\/10.1007\/s40263-019-00657-9","journal-title":"CNS Drugs"},{"key":"5263_CR94","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.12659\/MSM.891030","volume":"20","author":"T Zhang","year":"2014","unstructured":"Zhang T, Jia Y (2014) Meta-analysis of ubiquilin1 gene polymorphism and Alzheimer\u2019s disease risk. Med Sci Monit 20:2250\u20132255.","journal-title":"Med Sci Monit"},{"key":"5263_CR95","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13287-024-03789-y","volume":"15","author":"S Zhao","year":"2024","unstructured":"Zhao S, Li J, Duan S et al (2024) UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells. Stem Cell Res Ther 15:180. https:\/\/doi.org\/10.1186\/s13287-024-03789-y","journal-title":"Stem Cell Res Ther"},{"key":"5263_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder NA, Silva GM (2021) Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J Biol Chem 297:101077. https:\/\/doi.org\/10.1016\/j.jbc.2021.101077","journal-title":"J Biol Chem"},{"key":"5263_CR97","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.freeradbiomed.2021.10.036","volume":"177","author":"DA Butterfield","year":"2021","unstructured":"Butterfield DA (2021) Ubiquitin carboxyl-terminal hydrolase L-1 in brain: focus on its oxidative\/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment. Free Radical Biol Med 177:278\u2013286. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.10.036","journal-title":"Free Radical Biol Med"},{"key":"5263_CR98","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006361","volume":"2","author":"Y Ihara","year":"2012","unstructured":"Ihara Y, Morishima-Kawashima M, Nixon R (2012) The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006361. https:\/\/doi.org\/10.1101\/cshperspect.a006361","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5263_CR99","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","volume":"126","author":"B Gong","year":"2006","unstructured":"Gong B, Cao Z, Zheng P et al (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126:775\u2013788. https:\/\/doi.org\/10.1016\/j.cell.2006.06.046","journal-title":"Cell"},{"key":"5263_CR100","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2756068","volume":"2016","author":"A Tramutola","year":"2016","unstructured":"Tramutola A, Di Domenico F, Barone E et al (2016) It Is all about (u)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxid Med Cell Longev 2016:e2756068. https:\/\/doi.org\/10.1155\/2016\/2756068","journal-title":"Oxid Med Cell Longev"},{"key":"5263_CR101","doi-asserted-by":"publisher","first-page":"19209","DOI":"10.1074\/jbc.M117.815126","volume":"292","author":"M Boselli","year":"2017","unstructured":"Boselli M, Lee B-H, Robert J et al (2017) An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons. J Biol Chem 292:19209\u201319225. https:\/\/doi.org\/10.1074\/jbc.M117.815126","journal-title":"J Biol Chem"},{"key":"5263_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.801328","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang F, Ning S, Yu B, Wang Y (2022) USP14: structure, function, and target inhibition. Front Pharmacol 12:801328. https:\/\/doi.org\/10.3389\/fphar.2021.801328","journal-title":"Front Pharmacol"},{"key":"5263_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121789","volume":"11","author":"DE George","year":"2021","unstructured":"George DE, Tepe JJ (2021) Advances in proteasome enhancement by small molecules. Biomolecules 11:1789. https:\/\/doi.org\/10.3390\/biom11121789","journal-title":"Biomolecules"},{"key":"5263_CR104","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1021\/acschembio.4c00341","volume":"20","author":"J Witkowska","year":"2025","unstructured":"Witkowska J, Gi\u017cy\u0144ska M, Karpowicz P et al (2025) Blm10-based compounds add to the knowledge of how allosteric modulators influence human 20S proteasome. ACS Chem Biol 20:266\u2013280. https:\/\/doi.org\/10.1021\/acschembio.4c00341","journal-title":"ACS Chem Biol"},{"key":"5263_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060777","volume":"12","author":"K Ceka\u0142a","year":"2022","unstructured":"Ceka\u0142a K, Trepczyk K, Sowik D et al (2022) Peptidomimetics based on C-Terminus of Blm10 stimulate human 20S proteasome activity and promote degradation of proteins. Biomolecules 12:777. https:\/\/doi.org\/10.3390\/biom12060777","journal-title":"Biomolecules"},{"key":"5263_CR106","doi-asserted-by":"publisher","first-page":"104519","DOI":"10.1016\/j.isci.2022.104519","volume":"25","author":"Y Guo","year":"2022","unstructured":"Guo Y, AlisonA Chomiak, Hong Y et al (2022) Histone H2A ubiquitination resulting from Brap loss of function connects multiple aging hallmarks and accelerates neurodegeneration. iScience 25:104519. https:\/\/doi.org\/10.1016\/j.isci.2022.104519","journal-title":"iScience"},{"key":"5263_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12079-019-00538-2","volume":"14","author":"M Urulangodi","year":"2020","unstructured":"Urulangodi M, Mohanty A (2020) DNA damage response and repair pathway modulation by non-histone protein methylation: implications in neurodegeneration. J Cell Commun Signal 14:31\u201345. https:\/\/doi.org\/10.1007\/s12079-019-00538-2","journal-title":"J Cell Commun Signal"},{"key":"5263_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158187","volume":"23","author":"M Sekiguchi","year":"2022","unstructured":"Sekiguchi M, Matsushita N (2022) DNA damage response regulation by histone ubiquitination. Int J Mol Sci 23:8187. https:\/\/doi.org\/10.3390\/ijms23158187","journal-title":"Int J Mol Sci"},{"key":"5263_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2024.195033","volume":"1867","author":"A Dasgupta","year":"2024","unstructured":"Dasgupta A, Nandi S, Gupta S et al (2024) To Ub or not to Ub: the epic dilemma of histones that regulate gene expression and epigenetic cross-talk. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1867:195033. https:\/\/doi.org\/10.1016\/j.bbagrm.2024.195033","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"5263_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109704","volume":"36","author":"C Lowden","year":"2021","unstructured":"Lowden C, Boulet A, Boehler NA et al (2021) Homeostatic control of nuclear-encoded mitochondrial gene expression by the histone variant H2A.Z is essential for neuronal survival. Cell Reports 36:109704. https:\/\/doi.org\/10.1016\/j.celrep.2021.109704","journal-title":"Cell Reports"},{"key":"5263_CR111","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","volume":"15","author":"T Bhattacharya","year":"2022","unstructured":"Bhattacharya T, Soares GABE, Chopra H et al (2022) Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials (Basel) 15:804. https:\/\/doi.org\/10.3390\/ma15030804","journal-title":"Materials (Basel)"},{"key":"5263_CR112","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-160921","volume":"7","author":"E Bentea","year":"2016","unstructured":"Bentea E, Verbruggen L, Massie A (2016) The proteasome inhibition model of Parkinson\u2019s disease. J Parkinsons Dis 7:31\u201363. https:\/\/doi.org\/10.3233\/JPD-160921","journal-title":"J Parkinsons Dis"},{"key":"5263_CR113","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/35086067","volume":"2","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Olanow CW, Halliwell B et al (2001) Failure of the ubiquitin-proteasome system in Parkinson\u2019s disease. Nat Rev Neurosci 2:589\u2013594. https:\/\/doi.org\/10.1038\/35086067","journal-title":"Nat Rev Neurosci"},{"key":"5263_CR114","doi-asserted-by":"publisher","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P et al (2021) Alpha-synuclein aggregation in Parkinson\u2019s disease. Front Med 8. https:\/\/doi.org\/10.3389\/fmed.2021.736978","DOI":"10.3389\/fmed.2021.736978"},{"key":"5263_CR115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E et al (2020) Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein. Acta Neuropathol Commun 8:17. https:\/\/doi.org\/10.1186\/s40478-020-0894-0","journal-title":"Acta Neuropathol Commun"},{"key":"5263_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00377","volume":"9","author":"T Li","year":"2018","unstructured":"Li T, Feng Y, Yang R et al (2018) Salidroside promotes the pathological \u03b1-synuclein clearance through ubiquitin-proteasome system in SH-SY5Y cells. Front Pharmacol 9:377. https:\/\/doi.org\/10.3389\/fphar.2018.00377","journal-title":"Front Pharmacol"},{"key":"5263_CR117","doi-asserted-by":"publisher","first-page":"17510","DOI":"10.1073\/pnas.0405313101","volume":"101","author":"C Lo Bianco","year":"2004","unstructured":"Lo Bianco C, Schneider BL, Bauer M et al (2004) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 101:17510\u201317515. https:\/\/doi.org\/10.1073\/pnas.0405313101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR118","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/brain\/aww238","volume":"139","author":"W Wrasidlo","year":"2016","unstructured":"Wrasidlo W, Tsigelny IF, Price DL et al (2016) A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson\u2019s disease. Brain 139:3217\u20133236. https:\/\/doi.org\/10.1093\/brain\/aww238","journal-title":"Brain"},{"key":"5263_CR119","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.nbd.2015.09.009","volume":"82","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E et al (2015) Glucocerebrosidase gene therapy prevents \u03b1-synucleinopathy of midbrain dopamine neurons. Neurobiol Dis 82:495\u2013503. https:\/\/doi.org\/10.1016\/j.nbd.2015.09.009","journal-title":"Neurobiol Dis"},{"key":"5263_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152842","volume":"61","author":"C-Z Cai","year":"2019","unstructured":"Cai C-Z, Zhou H-F, Yuan N-N et al (2019) Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation. Phytomedicine 61:152842. https:\/\/doi.org\/10.1016\/j.phymed.2019.152842","journal-title":"Phytomedicine"},{"key":"5263_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109841","volume":"354","author":"KA El-Saiy","year":"2022","unstructured":"El-Saiy KA, Sayed RH, El-Sahar AE, Kandil EA (2022) Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson\u2019s disease model in rats. Chem Biol Interact 354:109841. https:\/\/doi.org\/10.1016\/j.cbi.2022.109841","journal-title":"Chem Biol Interact"},{"key":"5263_CR122","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, H\u00f8jrup P et al (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279:12924\u201312934. https:\/\/doi.org\/10.1074\/jbc.M306390200","journal-title":"J Biol Chem"},{"key":"5263_CR123","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","volume":"59","author":"T Behl","year":"2022","unstructured":"Behl T, Kumar S, Althafar ZM et al (2022) Exploring the role of ubiquitin-proteasome system in Parkinson\u2019s disease. Mol Neurobiol 59:4257\u20134273. https:\/\/doi.org\/10.1007\/s12035-022-02851-1","journal-title":"Mol Neurobiol"},{"key":"5263_CR124","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/s0896-6273(02)01125-x","volume":"36","author":"L Petrucelli","year":"2002","unstructured":"Petrucelli L, O\u2019Farrell C, Lockhart PJ et al (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36:1007\u20131019. https:\/\/doi.org\/10.1016\/s0896-6273(02)01125-x","journal-title":"Neuron"},{"key":"5263_CR125","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ncb1441","volume":"8","author":"L Fallon","year":"2006","unstructured":"Fallon L, B\u00e9langer CML, Corera AT et al (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 8:834\u2013842. https:\/\/doi.org\/10.1038\/ncb1441","journal-title":"Nat Cell Biol"},{"key":"5263_CR126","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03073.x","volume":"93","author":"Y Iwakura","year":"2005","unstructured":"Iwakura Y, Piao Y-S, Mizuno M et al (2005) Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson\u2019s disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem 93:974\u2013983. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03073.x","journal-title":"J Neurochem"},{"key":"5263_CR127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1478-811X-7-24","volume":"7","author":"PM van Bergen En Henegouwen","year":"2009","unstructured":"van Bergen En Henegouwen PM (2009) Eps15: a multifunctional adaptor protein regulating intracellular trafficking. Cell Commun Signal 7:24. https:\/\/doi.org\/10.1186\/1478-811X-7-24","journal-title":"Cell Commun Signal"},{"key":"5263_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00038","volume":"4","author":"J-F Trempe","year":"2013","unstructured":"Trempe J-F, Fon EA (2013) Structure and function of Parkin, PINK1, and DJ-1, the three musketeers of neuroprotection. Front Neurol 4:38. https:\/\/doi.org\/10.3389\/fneur.2013.00038","journal-title":"Front Neurol"},{"key":"5263_CR129","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ana.10675","volume":"54","author":"PM Abou-Sleiman","year":"2003","unstructured":"Abou-Sleiman PM, Healy DG, Quinn N et al (2003) The role of pathogenic DJ-1 mutations in Parkinson\u2019s disease. Ann Neurol 54:283\u2013286. https:\/\/doi.org\/10.1002\/ana.10675","journal-title":"Ann Neurol"},{"key":"5263_CR130","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284","journal-title":"Science"},{"key":"5263_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2025.104023","volume":"134","author":"A Sharma","year":"2025","unstructured":"Sharma A, Mannan A, Singh TG (2025) Rethinking Parkinson\u2019s: the role of proteostasis networks and autophagy in disease progression. Mol Cell Neurosci 134:104023. https:\/\/doi.org\/10.1016\/j.mcn.2025.104023","journal-title":"Mol Cell Neurosci"},{"key":"5263_CR132","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I et al (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A 100:4078\u20134083. https:\/\/doi.org\/10.1073\/pnas.0737556100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR133","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1073\/pnas.1221132110","volume":"110","author":"ES Vincow","year":"2013","unstructured":"Vincow ES, Merrihew G, Thomas RE et al (2013) The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A 110:6400\u20136405. https:\/\/doi.org\/10.1073\/pnas.1221132110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR134","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11011-020-00636-w","volume":"36","author":"T Pingale","year":"2021","unstructured":"Pingale T, Gupta GL (2021) Current and emerging therapeutic targets for Parkinson\u2019s disease. Metab Brain Dis 36:13\u201327. https:\/\/doi.org\/10.1007\/s11011-020-00636-w","journal-title":"Metab Brain Dis"},{"key":"5263_CR135","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G et al (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395:451\u2013452. https:\/\/doi.org\/10.1038\/26652","journal-title":"Nature"},{"issue":"Suppl 1","key":"5263_CR136","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.expneurol.2004.08.021","volume":"191","author":"R Betarbet","year":"2005","unstructured":"Betarbet R, Sherer TB, Greenamyre JT (2005) Ubiquitin-proteasome system and Parkinson\u2019s diseases. Exp Neurol 191(Suppl 1):S17-27. https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.021","journal-title":"Exp Neurol"},{"key":"5263_CR137","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41598-018-22804-w","volume":"8","author":"HH Tran","year":"2018","unstructured":"Tran HH, Dang SNA, Nguyen TT et al (2018) Drosophila ubiquitin C-terminal hydrolase knockdown model of Parkinson\u2019s disease. Sci Rep 8:4468. https:\/\/doi.org\/10.1038\/s41598-018-22804-w","journal-title":"Sci Rep"},{"key":"5263_CR138","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1389203717666160217143721","volume":"18","author":"Y-TC Lee","year":"2017","unstructured":"Lee Y-TC, Hsu S-TD (2017) Familial mutations and post-translational modifications of UCH-L1 in Parkinson\u2019s disease and neurodegenerative disorders. Curr Protein Pept Sci 18:733\u2013745. https:\/\/doi.org\/10.2174\/1389203717666160217143721","journal-title":"Curr Protein Pept Sci"},{"key":"5263_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00299","volume":"12","author":"CR Fields","year":"2019","unstructured":"Fields CR, Bengoa-Vergniory N, Wade-Martins R (2019) Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease. Front Mol Neurosci 12:299. https:\/\/doi.org\/10.3389\/fnmol.2019.00299","journal-title":"Front Mol Neurosci"},{"key":"5263_CR140","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","volume":"8","author":"K-L Lim","year":"2007","unstructured":"Lim K-L, Tan JM (2007) Role of the ubiquitin proteasome system in Parkinson\u2019s disease. BMC Biochem 8:S13. https:\/\/doi.org\/10.1186\/1471-2091-8-S1-S13","journal-title":"BMC Biochem"},{"key":"5263_CR141","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam T-I, Panicker N et al (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med 24:931\u2013938. https:\/\/doi.org\/10.1038\/s41591-018-0051-5","journal-title":"Nat Med"},{"key":"5263_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-47","volume":"9","author":"J-Q Li","year":"2014","unstructured":"Li J-Q, Tan L, Yu J-T (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegeneration 9:47. https:\/\/doi.org\/10.1186\/1750-1326-9-47","journal-title":"Mol Neurodegeneration"},{"key":"5263_CR143","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41419-020-02953-5","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Hu Z-W, Mao C-Y et al (2020) CHIP as a therapeutic target for neurological diseases. Cell Death Dis 11:727. https:\/\/doi.org\/10.1038\/s41419-020-02953-5","journal-title":"Cell Death Dis"},{"key":"5263_CR144","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.4155\/fmc.12.110","volume":"4","author":"S Ray","year":"2012","unstructured":"Ray S, Liu M (2012) Current understanding of LRRK2 in Parkinson\u2019s disease: biochemical and structural features and inhibitor design. Future Med Chem 4:1701\u20131713. https:\/\/doi.org\/10.4155\/fmc.12.110","journal-title":"Future Med Chem"},{"key":"5263_CR145","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1038\/s41467-024-46554-8","volume":"15","author":"S Amartumur","year":"2024","unstructured":"Amartumur S, Nguyen H, Huynh T et al (2024) Neuropathogenesis-on-chips for neurodegenerative diseases. Nat Commun 15:2219. https:\/\/doi.org\/10.1038\/s41467-024-46554-8","journal-title":"Nat Commun"},{"key":"5263_CR146","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrd4432","volume":"13","author":"JR Skaar","year":"2014","unstructured":"Skaar JR, Pagan JK, Pagano M (2014) SCF ubiquitin ligase-targeted therapies. Nat Rev Drug Discov 13:889\u2013903. https:\/\/doi.org\/10.1038\/nrd4432","journal-title":"Nat Rev Drug Discov"},{"key":"5263_CR147","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mrrev.2018.10.001","volume":"778","author":"ZD Zhou","year":"2018","unstructured":"Zhou ZD, Lee JCT, Tan EK (2018) Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson\u2019s disease (PD). Mutat Res Rev Mutat Res 778:72\u201378. https:\/\/doi.org\/10.1016\/j.mrrev.2018.10.001","journal-title":"Mutat Res Rev Mutat Res"},{"key":"5263_CR148","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","volume":"25","author":"Y Liang","year":"2023","unstructured":"Liang Y, Zhong G, Ren M et al (2023) The role of ubiquitin\u2013proteasome system and mitophagy in the pathogenesis of Parkinson\u2019s disease. Neuromol Med 25:471\u2013488. https:\/\/doi.org\/10.1007\/s12017-023-08755-0","journal-title":"Neuromol Med"},{"key":"5263_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102279","volume":"96","author":"A Kaushik","year":"2024","unstructured":"Kaushik A, Parashar S, Ambasta RK, Kumar P (2024) Ubiquitin E3 ligases assisted technologies in protein degradation: sharing pathways in neurodegenerative disorders and cancer. Ageing Res Rev 96:102279. https:\/\/doi.org\/10.1016\/j.arr.2024.102279","journal-title":"Ageing Res Rev"},{"key":"5263_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21083028","volume":"21","author":"F Limanaqi","year":"2020","unstructured":"Limanaqi F, Biagioni F, Gambardella S et al (2020) Promiscuous roles of autophagy and proteasome in neurodegenerative proteinopathies. Int J Mol Sci 21:3028. https:\/\/doi.org\/10.3390\/ijms21083028","journal-title":"Int J Mol Sci"},{"key":"5263_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"5263_CR152","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2174\/1570159X18666201109090824","volume":"19","author":"S Vishwas","year":"2021","unstructured":"Vishwas S, Gulati M, Kapoor B et al (2021) Expanding the arsenal against Huntington\u2019s disease-herbal drugs and their nanoformulations. Curr Neuropharmacol 19:957\u2013989. https:\/\/doi.org\/10.2174\/1570159X18666201109090824","journal-title":"Curr Neuropharmacol"},{"key":"5263_CR153","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0896-6273(95)90138-8","volume":"15","author":"CA Ross","year":"1995","unstructured":"Ross CA (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15:493\u2013496. https:\/\/doi.org\/10.1016\/0896-6273(95)90138-8","journal-title":"Neuron"},{"key":"5263_CR154","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217\u2013247. https:\/\/doi.org\/10.1146\/annurev.neuro.23.1.217","journal-title":"Annu Rev Neurosci"},{"key":"5263_CR155","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes P, Wanker EE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28:425\u2013433. https:\/\/doi.org\/10.1016\/S0968-0004(03)00168-3","journal-title":"Trends Biochem Sci"},{"key":"5263_CR156","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.8303297","volume":"263","author":"HP Gerber","year":"1994","unstructured":"Gerber HP, Seipel K, Georgiev O et al (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808\u2013811. https:\/\/doi.org\/10.1126\/science.8303297","journal-title":"Science"},{"key":"5263_CR157","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4:387\u2013392. https:\/\/doi.org\/10.1038\/ng0893-387","journal-title":"Nat Genet"},{"key":"5263_CR158","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP et al (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 4:393\u2013397. https:\/\/doi.org\/10.1038\/ng0893-393","journal-title":"Nat Genet"},{"key":"5263_CR159","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","volume":"95","author":"BG Jenkins","year":"2005","unstructured":"Jenkins BG, Andreassen OA, Dedeoglu A et al (2005) Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington\u2019s disease. J Neurochem 95:553\u2013562. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03411.x","journal-title":"J Neurochem"},{"key":"5263_CR160","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981. https:\/\/doi.org\/10.1152\/physrev.00041.2009","journal-title":"Physiol Rev"},{"key":"5263_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105047","volume":"92","author":"P Singh","year":"2022","unstructured":"Singh P, Mishra G, Molla M et al (2022) Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington\u2019s disease. Journal of Functional Foods 92:105047. https:\/\/doi.org\/10.1016\/j.jff.2022.105047","journal-title":"Journal of Functional Foods"},{"key":"5263_CR162","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1021\/acs.accounts.0c00450","volume":"53","author":"R Wetzel","year":"2020","unstructured":"Wetzel R (2020) Exploding the repeat length paradigm while exploring amyloid toxicity in Huntington\u2019s disease. Acc Chem Res 53:2347\u20132357. https:\/\/doi.org\/10.1021\/acs.accounts.0c00450","journal-title":"Acc Chem Res"},{"key":"5263_CR163","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ng0696-196","volume":"13","author":"H Ikeda","year":"1996","unstructured":"Ikeda H, Yamaguchi M, Sugai S et al (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 13:196\u2013202. https:\/\/doi.org\/10.1038\/ng0696-196","journal-title":"Nat Genet"},{"key":"5263_CR164","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/s0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D et al (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24:182\u2013188. https:\/\/doi.org\/10.1016\/s0166-2236(00)01721-5","journal-title":"Trends Neurosci"},{"key":"5263_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00077","volume":"7","author":"Z Ortega","year":"2014","unstructured":"Ortega Z, Lucas JJ (2014) Ubiquitin\u2013proteasome system involvement in Huntington\u2019s disease. Front Mol Neurosci 7:77. https:\/\/doi.org\/10.3389\/fnmol.2014.00077","journal-title":"Front Mol Neurosci"},{"key":"5263_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000238","volume":"2","author":"H Seo","year":"2007","unstructured":"Seo H, Sonntag K-C, Kim W et al (2007) Proteasome activator enhances survival of Huntington\u2019s disease neuronal model cells. PLoS ONE 2:e238. https:\/\/doi.org\/10.1371\/journal.pone.0000238","journal-title":"PLoS ONE"},{"key":"5263_CR167","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1093\/hmg\/ddn218","volume":"17","author":"HK Wong","year":"2008","unstructured":"Wong HK, Bauer PO, Kurosawa M et al (2008) Blocking acid-sensing ion channel 1 alleviates Huntington\u2019s disease pathology via an ubiquitin-proteasome system-dependent mechanism. Hum Mol Genet 17:3223\u20133235. https:\/\/doi.org\/10.1093\/hmg\/ddn218","journal-title":"Hum Mol Genet"},{"key":"5263_CR168","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.bbrc.2013.12.034","volume":"443","author":"W Kim","year":"2014","unstructured":"Kim W, Seo H (2014) Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington\u2019s disease model mice. Biochem Biophys Res Commun 443:706\u2013711. https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.034","journal-title":"Biochem Biophys Res Commun"},{"key":"5263_CR169","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jep.2011.08.075","volume":"138","author":"C-L Huang","year":"2011","unstructured":"Huang C-L, Yang J-M, Wang K-C et al (2011) Gastrodia elata prevents huntingtin aggregations through activation of the adenosine A\u2082A receptor and ubiquitin proteasome system. J Ethnopharmacol 138:162\u2013168. https:\/\/doi.org\/10.1016\/j.jep.2011.08.075","journal-title":"J Ethnopharmacol"},{"key":"5263_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124282","volume":"21","author":"B Lontay","year":"2020","unstructured":"Lontay B, Kiss A, Vir\u00e1g L, Tar K (2020) How Do post-translational modifications influence the pathomechanistic landscape of Huntington\u2019s disease? A Comprehensive Review. Int J Mol Sci 21:4282. https:\/\/doi.org\/10.3390\/ijms21124282","journal-title":"Int J Mol Sci"},{"key":"5263_CR171","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1093\/hmg\/dds379","volume":"21","author":"H Jia","year":"2012","unstructured":"Jia H, Kast RJ, Steffan JS, Thomas EA (2012) Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington\u2019s disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum Mol Genet 21:5280\u20135293. https:\/\/doi.org\/10.1093\/hmg\/dds379","journal-title":"Hum Mol Genet"},{"key":"5263_CR172","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jnc.12647","volume":"129","author":"Y Liu","year":"2014","unstructured":"Liu Y, Hettinger CL, Zhang D et al (2014) Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington\u2019s disease. J Neurochem 129:539\u2013547. https:\/\/doi.org\/10.1111\/jnc.12647","journal-title":"J Neurochem"},{"key":"5263_CR173","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuroscience.2016.02.054","volume":"324","author":"J Jeon","year":"2016","unstructured":"Jeon J, Kim W, Jang J et al (2016) Gene therapy by proteasome activator, PA28\u03b3, improves motor coordination and proteasome function in Huntington\u2019s disease YAC128 mice. Neuroscience 324:20\u201328. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.054","journal-title":"Neuroscience"},{"key":"5263_CR174","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/hmg\/ddaa061","volume":"29","author":"M Jiang","year":"2020","unstructured":"Jiang M, Zhang X, Liu H et al (2020) Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington\u2019s disease. Hum Mol Genet 29:1340\u20131352. https:\/\/doi.org\/10.1093\/hmg\/ddaa061","journal-title":"Hum Mol Genet"},{"key":"5263_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168936","volume":"23","author":"M Merino","year":"2022","unstructured":"Merino M, Sequedo MD, S\u00e1nchez-S\u00e1nchez AV et al (2022) Mn(II) quinoline complex (4QMn) restores proteostasis and reduces toxicity in experimental models of Huntington\u2019s disease. Int J Mol Sci 23:8936. https:\/\/doi.org\/10.3390\/ijms23168936","journal-title":"Int J Mol Sci"},{"key":"5263_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040948","volume":"10","author":"G Pannafino","year":"2021","unstructured":"Pannafino G, Alani E (2021) Coordinated and independent roles for MLH subunits in DNA repair. Cells 10:948. https:\/\/doi.org\/10.3390\/cells10040948","journal-title":"Cells"},{"key":"5263_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109649","volume":"36","author":"R Goold","year":"2021","unstructured":"Goold R, Hamilton J, Menneteau T et al (2021) FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington\u2019s disease. Cell Reports 36:109649. https:\/\/doi.org\/10.1016\/j.celrep.2021.109649","journal-title":"Cell Reports"},{"key":"5263_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003930","volume":"9","author":"RM Pinto","year":"2013","unstructured":"Pinto RM, Dragileva E, Kirby A et al (2013) Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet 9:e1003930. https:\/\/doi.org\/10.1371\/journal.pgen.1003930","journal-title":"PLoS Genet"},{"key":"5263_CR179","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","volume":"107","author":"K-H Kim","year":"2020","unstructured":"Kim K-H, Hong EP, Shin JW et al (2020) Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. The American Journal of Human Genetics 107:96\u2013110. https:\/\/doi.org\/10.1016\/j.ajhg.2020.05.012","journal-title":"The American Journal of Human Genetics"},{"key":"5263_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051019","volume":"10","author":"G-F Richard","year":"2021","unstructured":"Richard G-F (2021) The startling role of mismatch repair in trinucleotide repeat expansions. Cells 10:1019. https:\/\/doi.org\/10.3390\/cells10051019","journal-title":"Cells"},{"key":"5263_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158323","volume":"22","author":"JG Kim","year":"2021","unstructured":"Kim JG, Shin H-C, Seo T et al (2021) Signaling pathways regulated by UBR Box-containing E3 ligases. Int J Mol Sci 22:8323. https:\/\/doi.org\/10.3390\/ijms22158323","journal-title":"Int J Mol Sci"},{"key":"5263_CR182","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1016\/j.csbj.2021.07.018","volume":"19","author":"Y Ajjugal","year":"2021","unstructured":"Ajjugal Y, Rathinavelan T (2021) Conformational distortions induced by periodically recurring A\u2026A in d(CAG).d(CAG) provide stereochemical rationale for the trapping of MSH2.MSH3 in polyQ disorders. Comput Struct Biotechnol J 19:4447\u20134455. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.018","journal-title":"Comput Struct Biotechnol J"},{"key":"5263_CR183","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16:529\u2013546. https:\/\/doi.org\/10.1038\/s41582-020-0389-4","journal-title":"Nat Rev Neurol"},{"key":"5263_CR184","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mrfmmm.2012.12.008","volume":"743\u2013744","author":"MA Edelbrock","year":"2013","unstructured":"Edelbrock MA, Kaliyaperumal S, Williams KJ (2013) Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis 743\u2013744:53\u201366. https:\/\/doi.org\/10.1016\/j.mrfmmm.2012.12.008","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"5263_CR185","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2023.05.010","volume":"31","author":"R Ferguson","year":"2023","unstructured":"Ferguson R, Tabrizi SJ (2023) Can MSH3 lowering stop HTT repeat expansion in its CAG tract? Mol Ther 31:1509\u20131511. https:\/\/doi.org\/10.1016\/j.ymthe.2023.05.010","journal-title":"Mol Ther"},{"key":"5263_CR186","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0022-2836(02)01090-2","volume":"324","author":"RMF Cardoso","year":"2002","unstructured":"Cardoso RMF, Thayer MM, DiDonato M et al (2002) Insights into Lou Gehrig\u2019s disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. J Mol Biol 324:247\u2013256. https:\/\/doi.org\/10.1016\/s0022-2836(02)01090-2","journal-title":"J Mol Biol"},{"key":"5263_CR187","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L et al (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https:\/\/doi.org\/10.4103\/2152-7806.169561","journal-title":"Surg Neurol Int"},{"key":"5263_CR188","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"H-X Deng","year":"2011","unstructured":"Deng H-X, Chen W, Hong S-T et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477:211\u2013215. https:\/\/doi.org\/10.1038\/nature10353","journal-title":"Nature"},{"key":"5263_CR189","doi-asserted-by":"publisher","first-page":"e106389","DOI":"10.15252\/embj.2020106389","volume":"40","author":"ME Cicardi","year":"2021","unstructured":"Cicardi ME, Marrone L, Azzouz M, Trotti D (2021) Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J 40:e106389. https:\/\/doi.org\/10.15252\/embj.2020106389","journal-title":"EMBO J"},{"key":"5263_CR190","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","volume":"8","author":"F Shu","year":"2023","unstructured":"Shu F, Xiao H, Li Q-N et al (2023) Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Sig Transduct Target Ther 8:32. https:\/\/doi.org\/10.1038\/s41392-022-01300-8","journal-title":"Sig Transduct Target Ther"},{"key":"5263_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112349","volume":"9","author":"A Vainshtein","year":"2020","unstructured":"Vainshtein A, Grumati P (2020) Selective autophagy by close encounters of the ubiquitin kind. Cells 9:2349. https:\/\/doi.org\/10.3390\/cells9112349","journal-title":"Cells"},{"key":"5263_CR192","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/15548627.2017.1391970","volume":"14","author":"F Li","year":"2018","unstructured":"Li F, Xu D, Wang Y et al (2018) Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy 14:66\u201379. https:\/\/doi.org\/10.1080\/15548627.2017.1391970","journal-title":"Autophagy"},{"key":"5263_CR193","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426:895\u2013899. https:\/\/doi.org\/10.1038\/nature02263","journal-title":"Nature"},{"key":"5263_CR194","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s12031-022-02029-3","volume":"72","author":"M Cozzi","year":"2022","unstructured":"Cozzi M, Ferrari V (2022) Autophagy dysfunction in ALS: from transport to protein degradation. J Mol Neurosci 72:1456\u20131481. https:\/\/doi.org\/10.1007\/s12031-022-02029-3","journal-title":"J Mol Neurosci"},{"key":"5263_CR195","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuint.2014.10.007","volume":"79","author":"M Galbiati","year":"2014","unstructured":"Galbiati M, Crippa V, Rusmini P et al (2014) ALS-related misfolded protein management in motor neurons and muscle cells. Neurochem Int 79:70\u201378. https:\/\/doi.org\/10.1016\/j.neuint.2014.10.007","journal-title":"Neurochem Int"},{"key":"5263_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103464","volume":"21","author":"J Pham","year":"2020","unstructured":"Pham J, Keon M, Brennan S, Saksena N (2020) Connecting RNA-modifying similarities of TDP-43, FUS, and SOD1 with microRNA dysregulation amidst a renewed network perspective of amyotrophic lateral sclerosis proteinopathy. Int J Mol Sci 21:3464. https:\/\/doi.org\/10.3390\/ijms21103464","journal-title":"Int J Mol Sci"},{"key":"5263_CR197","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tma.2023.09.001","volume":"7","author":"P Kumar","year":"2023","unstructured":"Kumar P, Choudhary A, Kinger S et al (2023) Proteostasis defects: medicinal challenges of imperfect aging & neurodegeneration. Translational Medicine of Aging 7:87\u201397. https:\/\/doi.org\/10.1016\/j.tma.2023.09.001","journal-title":"Translational Medicine of Aging"},{"key":"5263_CR198","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1021\/cn500147v","volume":"5","author":"PC Trippier","year":"2014","unstructured":"Trippier PC, Zhao KT, Fox SG et al (2014) Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis. ACS Chem Neurosci 5:823\u2013829. https:\/\/doi.org\/10.1021\/cn500147v","journal-title":"ACS Chem Neurosci"},{"key":"5263_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-13-179","volume":"13","author":"SH Kim","year":"2013","unstructured":"Kim SH, Jung SY, Lee K-W et al (2013) Bee venom effects on ubiquitin proteasome system in hSOD1(G85R)-expressing NSC34 motor neuron cells. BMC Complement Altern Med 13:179. https:\/\/doi.org\/10.1186\/1472-6882-13-179","journal-title":"BMC Complement Altern Med"},{"key":"5263_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-69","volume":"8","author":"EJ Yang","year":"2011","unstructured":"Yang EJ, Kim SH, Yang SC et al (2011) Melittin restores proteasome function in an animal model of ALS. J Neuroinflammation 8:69. https:\/\/doi.org\/10.1186\/1742-2094-8-69","journal-title":"J Neuroinflammation"},{"key":"5263_CR201","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12929-023-00921-7","volume":"30","author":"Y-L Tseng","year":"2023","unstructured":"Tseng Y-L, Lu P-C, Lee C-C et al (2023) Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera. J Biomed Sci 30:27. https:\/\/doi.org\/10.1186\/s12929-023-00921-7","journal-title":"J Biomed Sci"},{"key":"5263_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V et al (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12:25. https:\/\/doi.org\/10.3389\/fnmol.2019.00025","journal-title":"Front Mol Neurosci"},{"key":"5263_CR203","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegeneration 15:45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","journal-title":"Mol Neurodegeneration"},{"key":"5263_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102229","volume":"211","author":"SS Keating","year":"2022","unstructured":"Keating SS, San Gil R, Swanson MEV et al (2022) TDP-43 pathology: from noxious assembly to therapeutic removal. Prog Neurobiol 211:102229. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102229","journal-title":"Prog Neurobiol"},{"key":"5263_CR205","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bbrc.2016.02.107","volume":"472","author":"M Osaka","year":"2016","unstructured":"Osaka M, Ito D, Suzuki N (2016) Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem Biophys Res Commun 472:324\u2013331. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.107","journal-title":"Biochem Biophys Res Commun"},{"key":"5263_CR206","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40478-019-0758-7","volume":"7","author":"L Renaud","year":"2019","unstructured":"Renaud L, Picher-Martel V, Codron P, Julien J-P (2019) Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun 7:103. https:\/\/doi.org\/10.1186\/s40478-019-0758-7","journal-title":"Acta Neuropathol Commun"},{"key":"5263_CR207","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto F, Yan J, Vemula SP et al (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68:1440\u20131446. https:\/\/doi.org\/10.1001\/archneurol.2011.250","journal-title":"Arch Neurol"},{"key":"5263_CR208","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.4103\/1673-5374.284977","volume":"15","author":"AD Foster","year":"2020","unstructured":"Foster AD, Rea SL (2020) The role of sequestosome 1\/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen Res 15:2186\u20132194. https:\/\/doi.org\/10.4103\/1673-5374.284977","journal-title":"Neural Regen Res"},{"key":"5263_CR209","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/hmg\/ddw180","volume":"25","author":"S Hadano","year":"2016","unstructured":"Hadano S, Mitsui S, Pan L et al (2016) Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet 25:3321\u20133340. https:\/\/doi.org\/10.1093\/hmg\/ddw180","journal-title":"Hum Mol Genet"},{"key":"5263_CR210","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13041-018-0373-8","volume":"11","author":"S Mitsui","year":"2018","unstructured":"Mitsui S, Otomo A, Nozaki M et al (2018) Systemic overexpression of SQSTM1\/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model. Mol Brain 11:30. https:\/\/doi.org\/10.1186\/s13041-018-0373-8","journal-title":"Mol Brain"},{"key":"5263_CR211","doi-asserted-by":"publisher","unstructured":"Windham B, Mannyam CS, Shukla S (2022) SQSTM1 gene mutation causing slowly progressive motor neuron disease (P1\u20131.Virtual). Neurology 98 (18_supplement). https:\/\/doi.org\/10.1212\/WNL.98.18_supplement.3366","DOI":"10.1212\/WNL.98.18_supplement.3366"},{"key":"5263_CR212","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.15252\/embj.201797568","volume":"36","author":"F-B Gao","year":"2017","unstructured":"Gao F-B, Almeida S, Lopez-Gonzalez R (2017) Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J 36:2931\u20132950. https:\/\/doi.org\/10.15252\/embj.201797568","journal-title":"EMBO J"},{"key":"5263_CR213","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.841394","volume":"13","author":"E Scarian","year":"2022","unstructured":"Scarian E, Fiamingo G, Diamanti L et al (2022) The role of VCP mutations in the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia. Front Neurol 13:841394. https:\/\/doi.org\/10.3389\/fneur.2022.841394","journal-title":"Front Neurol"},{"key":"5263_CR214","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-014-0172-0","volume":"2","author":"T Ayaki","year":"2014","unstructured":"Ayaki T, Ito H, Fukushima H et al (2014) Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant. Acta Neuropathol Commun 2:172. https:\/\/doi.org\/10.1186\/s40478-014-0172-0","journal-title":"Acta Neuropathol Commun"},{"key":"5263_CR215","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1038\/cddis.2012.115","volume":"3","author":"HZ Yin","year":"2012","unstructured":"Yin HZ, Nalbandian A, Hsu C-I et al (2012) Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis 3:e374\u2013e374. https:\/\/doi.org\/10.1038\/cddis.2012.115","journal-title":"Cell Death Dis"},{"key":"5263_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/biology8020036","volume":"8","author":"V Granatiero","year":"2019","unstructured":"Granatiero V, Manfredi G (2019) Mitochondrial transport and turnover in the pathogenesis of amyotrophic lateral sclerosis. Biology 8:36. https:\/\/doi.org\/10.3390\/biology8020036","journal-title":"Biology"},{"key":"5263_CR217","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.celrep.2017.05.024","volume":"19","author":"CE Hall","year":"2017","unstructured":"Hall CE, Yao Z, Choi M et al (2017) Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep 19:1739\u20131749. https:\/\/doi.org\/10.1016\/j.celrep.2017.05.024","journal-title":"Cell Rep"},{"key":"5263_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1319706","volume":"17","author":"S Zhao","year":"2023","unstructured":"Zhao S, Chen R, Gao Y et al (2023) Fundamental roles of the Optineurin gene in the molecular pathology of amyotrophic lateral sclerosis. Front Neurosci 17:1319706. https:\/\/doi.org\/10.3389\/fnins.2023.1319706","journal-title":"Front Neurosci"},{"key":"5263_CR219","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jnen\/nlx109","volume":"77","author":"T Ayaki","year":"2018","unstructured":"Ayaki T, Ito H, Komure O et al (2018) Multiple proteinopathies in familial ALS cases with optineurin mutations. J Neuropathol Exp Neurol 77:128\u2013138. https:\/\/doi.org\/10.1093\/jnen\/nlx109","journal-title":"J Neuropathol Exp Neurol"},{"key":"5263_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02647","volume":"9","author":"Z Liu","year":"2018","unstructured":"Liu Z, Li H, Hong C et al (2018) ALS-associated E478G mutation in human OPTN (Optineurin) promotes inflammation and induces neuronal cell death. Front Immunol 9:2647. https:\/\/doi.org\/10.3389\/fimmu.2018.02647","journal-title":"Front Immunol"},{"key":"5263_CR221","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/auto.36098","volume":"11","author":"W-C Shen","year":"2015","unstructured":"Shen W-C, Li H-Y, Chen G-C et al (2015) Mutations in the ubiquitin-binding domain of OPTN\/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 11:685\u2013700. https:\/\/doi.org\/10.4161\/auto.36098","journal-title":"Autophagy"},{"key":"5263_CR222","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70029","volume":"42","author":"Y Guo","year":"2024","unstructured":"Guo Y, Tian Y, Xia P et al (2024) Exploring the function of OPTN from multiple dimensions. Cell Biochem Funct 42:e70029. https:\/\/doi.org\/10.1002\/cbf.70029","journal-title":"Cell Biochem Funct"},{"key":"5263_CR223","doi-asserted-by":"publisher","first-page":"266.e1","DOI":"10.1016\/j.neurobiolaging.2018.06.015","volume":"71","author":"M de Majo","year":"2018","unstructured":"de Majo M, Topp SD, Smith BN et al (2018) ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol Aging 71:266.e1-266.e10. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.015","journal-title":"Neurobiol Aging"},{"key":"5263_CR224","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","volume":"10","author":"JA Oakes","year":"2017","unstructured":"Oakes JA, Davies MC, Collins MO (2017) TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 10:5. https:\/\/doi.org\/10.1186\/s13041-017-0287-x","journal-title":"Mol Brain"},{"key":"5263_CR225","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1021\/cr800413p","volume":"109","author":"C Grabbe","year":"2009","unstructured":"Grabbe C, Dikic I (2009) Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. Chem Rev 109:1481\u20131494. https:\/\/doi.org\/10.1021\/cr800413p","journal-title":"Chem Rev"},{"key":"5263_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020381","volume":"9","author":"E Vicencio","year":"2020","unstructured":"Vicencio E, Beltr\u00e1n S, Labrador L et al (2020) Implications of selective autophagy dysfunction for ALS pathology. Cells 9:381. https:\/\/doi.org\/10.3390\/cells9020381","journal-title":"Cells"},{"key":"5263_CR227","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.molmed.2016.04.006","volume":"22","author":"L Ahmad","year":"2016","unstructured":"Ahmad L, Zhang S-Y, Casanova J-L, Sancho-Shimizu V (2016) Human TBK1: a gatekeeper of neuroinflammation. Trends Mol Med 22:511\u2013527. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.006","journal-title":"Trends Mol Med"},{"key":"5263_CR228","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/15548627.2021.1926656","volume":"18","author":"JP Chua","year":"2022","unstructured":"Chua JP, De Calbiac H, Kabashi E, Barmada SJ (2022) Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy 18:254\u2013282. https:\/\/doi.org\/10.1080\/15548627.2021.1926656","journal-title":"Autophagy"},{"key":"5263_CR229","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-018-0579-0","volume":"6","author":"P Frick","year":"2018","unstructured":"Frick P, Sellier C, Mackenzie IRA et al (2018) Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun 6:72. https:\/\/doi.org\/10.1186\/s40478-018-0579-0","journal-title":"Acta Neuropathol Commun"},{"key":"5263_CR230","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ejhg.2012.98","volume":"21","author":"BN Smith","year":"2013","unstructured":"Smith BN, Newhouse S, Shatunov A et al (2013) The C9ORF72 expansion mutation is a common cause of ALS+\/-FTD in Europe and has a single founder. Eur J Hum Genet 21:102\u2013108. https:\/\/doi.org\/10.1038\/ejhg.2012.98","journal-title":"Eur J Hum Genet"},{"key":"5263_CR231","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00151","volume":"13","author":"L Latonen","year":"2019","unstructured":"Latonen L (2019) Phase-to-phase with nucleoli \u2013 stress responses, protein aggregation and novel roles of RNA. Front Cell Neurosci 13:151. https:\/\/doi.org\/10.3389\/fncel.2019.00151","journal-title":"Front Cell Neurosci"},{"key":"5263_CR232","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544\u2013558. https:\/\/doi.org\/10.1038\/s41582-018-0047-2","journal-title":"Nat Rev Neurol"},{"key":"5263_CR233","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.562758","volume":"11","author":"Q Yang","year":"2020","unstructured":"Yang Q, Jiao B, Shen L (2020) The development of C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia disorders. Front Genet 11:562758. https:\/\/doi.org\/10.3389\/fgene.2020.562758","journal-title":"Front Genet"},{"key":"5263_CR234","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.637548","volume":"15","author":"A Schmitz","year":"2021","unstructured":"Schmitz A, Pinheiro Marques J, Oertig I et al (2021) Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS\/FTD. Front Cell Neurosci 15:637548. https:\/\/doi.org\/10.3389\/fncel.2021.637548","journal-title":"Front Cell Neurosci"},{"key":"5263_CR235","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang K, Donnelly CJ, Haeusler AR et al (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525:56\u201361. https:\/\/doi.org\/10.1038\/nature14973","journal-title":"Nature"},{"key":"5263_CR236","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020178","volume":"13","author":"PH Smeele","year":"2024","unstructured":"Smeele PH, Cesare G, Vaccari T (2024) ALS\u2019 perfect storm: C9orf72-associated toxic dipeptide repeats as potential multipotent disruptors of protein homeostasis. Cells 13:178. https:\/\/doi.org\/10.3390\/cells13020178","journal-title":"Cells"},{"key":"5263_CR237","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-020-00383-7","volume":"15","author":"X Tang","year":"2020","unstructured":"Tang X, Toro A, Sahana TG et al (2020) Divergence, convergence, and therapeutic implications: a cell biology perspective of C9ORF72-ALS\/FTD. Mol Neurodegeneration 15:34. https:\/\/doi.org\/10.1186\/s13024-020-00383-7","journal-title":"Mol Neurodegeneration"},{"key":"5263_CR238","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pneurobio.2009.10.020","volume":"90","author":"INM Day","year":"2010","unstructured":"Day INM, Thompson RJ (2010) UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Prog Neurobiol 90:327\u2013362. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.10.020","journal-title":"Prog Neurobiol"},{"key":"5263_CR239","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2017.08.023","volume":"60","author":"Y-L Cao","year":"2017","unstructured":"Cao Y-L, Yang Y-P, Mao C-J et al (2017) A role of BAG3 in regulating SNCA\/\u03b1-synuclein clearance via selective macroautophagy. Neurobiol Aging 60:104\u2013115. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.08.023","journal-title":"Neurobiol Aging"},{"key":"5263_CR240","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1073858408327809","volume":"15","author":"R Meller","year":"2009","unstructured":"Meller R (2009) The role of the ubiquitin proteasome system in ischemia and ischemic tolerance. Neuroscientist 15:243\u2013260. https:\/\/doi.org\/10.1177\/1073858408327809","journal-title":"Neuroscientist"},{"key":"5263_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102255","volume":"96","author":"PS Rakshe","year":"2024","unstructured":"Rakshe PS, Dutta BJ, Chib S et al (2024) Unveiling the interplay of AMPK\/SIRT1\/PGC-1\u03b1 axis in brain health: promising targets against aging and NDDs. Ageing Res Rev 96:102255. https:\/\/doi.org\/10.1016\/j.arr.2024.102255","journal-title":"Ageing Res Rev"},{"key":"5263_CR242","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1734-1140(10)70338-8","volume":"62","author":"J D\u0105bek","year":"2010","unstructured":"D\u0105bek J, Ku\u0142ach A, G\u0105sior Z (2010) Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB): a new potential therapeutic target in atherosclerosis? Pharmacol Rep 62:778\u2013783. https:\/\/doi.org\/10.1016\/S1734-1140(10)70338-8","journal-title":"Pharmacol Rep"},{"key":"5263_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00011","volume":"6","author":"I Gupta","year":"2018","unstructured":"Gupta I, Singh K, Varshney NK, Khan S (2018) Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis. Front Cell Dev Biol 6:11. https:\/\/doi.org\/10.3389\/fcell.2018.00011","journal-title":"Front Cell Dev Biol"},{"key":"5263_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168780","volume":"22","author":"M Akther","year":"2021","unstructured":"Akther M, Haque ME, Park J et al (2021) NLRP3 Ubiquitination\u2014a new approach to target NLRP3 inflammasome activation. Int J Mol Sci 22:8780. https:\/\/doi.org\/10.3390\/ijms22168780","journal-title":"Int J Mol Sci"},{"key":"5263_CR245","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s10565-023-09820-x","volume":"39","author":"K Wu","year":"2023","unstructured":"Wu K, Wang W, Cheng Q et al (2023) Pyroptosis in neurodegenerative diseases: from bench to bedside. Cell Biol Toxicol 39:2467\u20132499. https:\/\/doi.org\/10.1007\/s10565-023-09820-x","journal-title":"Cell Biol Toxicol"},{"key":"5263_CR246","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-015-0239-2","volume":"12","author":"G Santoni","year":"2015","unstructured":"Santoni G, Cardinali C, Morelli MB et al (2015) Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons. J Neuroinflammation 12:21. https:\/\/doi.org\/10.1186\/s12974-015-0239-2","journal-title":"J Neuroinflammation"},{"key":"5263_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103194","volume":"27","author":"A Rauf","year":"2022","unstructured":"Rauf A, Badoni H, Abu-Izneid T et al (2022) Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases. Molecules 27:3194. https:\/\/doi.org\/10.3390\/molecules27103194","journal-title":"Molecules"},{"key":"5263_CR248","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2024.07.001","volume":"49","author":"A Ulfig","year":"2024","unstructured":"Ulfig A, Jakob U (2024) Cellular oxidants and the proteostasis network: balance between activation and destruction. Trends Biochem Sci 49:761\u2013774. https:\/\/doi.org\/10.1016\/j.tibs.2024.07.001","journal-title":"Trends Biochem Sci"},{"key":"5263_CR249","doi-asserted-by":"publisher","DOI":"10.3390\/biology10020163","volume":"10","author":"S Gupta","year":"2021","unstructured":"Gupta S, You P, SenGupta T et al (2021) Crosstalk between different DNA repair pathways contributes to neurodegenerative diseases. Biology 10:163. https:\/\/doi.org\/10.3390\/biology10020163","journal-title":"Biology"},{"key":"5263_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050851","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Li S, Wu H (2022) Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 11:851. https:\/\/doi.org\/10.3390\/cells11050851","journal-title":"Cells"},{"key":"5263_CR251","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-01162-7","volume":"8","author":"W Wang","year":"2022","unstructured":"Wang W, Shi B, Cong R et al (2022) RING-finger E3 ligases regulatory network in PI3K\/AKT-mediated glucose metabolism. Cell Death Discov 8:1\u20139. https:\/\/doi.org\/10.1038\/s41420-022-01162-7","journal-title":"Cell Death Discov"},{"key":"5263_CR252","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1497555","volume":"19","author":"X Yang","year":"2025","unstructured":"Yang X, Liu T, Cheng H (2025) PTEN: a new dawn in Parkinson\u2019s disease treatment. Front Cell Neurosci 19:1497555. https:\/\/doi.org\/10.3389\/fncel.2025.1497555","journal-title":"Front Cell Neurosci"},{"key":"5263_CR253","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1007\/s12035-024-04608-4","volume":"62","author":"BK Utpal","year":"2025","unstructured":"Utpal BK, Mokhfi FZ, Zehravi M et al (2025) Resveratrol: a natural compound targeting the PI3K\/Akt\/mTOR pathway in neurological diseases. Mol Neurobiol 62:5579\u20135608. https:\/\/doi.org\/10.1007\/s12035-024-04608-4","journal-title":"Mol Neurobiol"},{"key":"5263_CR254","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011237","volume":"22","author":"C-S Khoi","year":"2021","unstructured":"Khoi C-S, Chen J-H, Lin T-Y et al (2021) Ochratoxin A-induced nephrotoxicity: up-to-date evidence. Int J Mol Sci 22:11237. https:\/\/doi.org\/10.3390\/ijms222011237","journal-title":"Int J Mol Sci"},{"key":"5263_CR255","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Hern\u00e1ndez-Dami\u00e1n J, Pedraza-Chaverri J (2014) The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 26:2694\u20132701. https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.019","journal-title":"Cell Signal"},{"key":"5263_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101963","volume":"88","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu Q, Zhang Z et al (2023) The regulatory role of PI3K in ageing-related diseases. Ageing Res Rev 88:101963. https:\/\/doi.org\/10.1016\/j.arr.2023.101963","journal-title":"Ageing Res Rev"},{"key":"5263_CR257","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1080\/14756366.2021.1955873","volume":"36","author":"Z Chrienova","year":"2021","unstructured":"Chrienova Z, Nepovimova E, Kuca K (2021) The role of mTOR in age-related diseases. J Enzyme Inhib Med Chem 36:1678\u20131692. https:\/\/doi.org\/10.1080\/14756366.2021.1955873","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5263_CR258","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/0115734013307906240407093309","volume":"21","author":"A Sharma","year":"2025","unstructured":"Sharma A, Kaur G, Kaur A, Devi S (2025) Unraveling the anti-obesity potential of luteolin: mechanistic insights. Curr Nutr Food Sci 21:295\u2013308. https:\/\/doi.org\/10.2174\/0115734013307906240407093309","journal-title":"Curr Nutr Food Sci"},{"key":"5263_CR259","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12264-023-01120-y","volume":"40","author":"Y-Y Li","year":"2024","unstructured":"Li Y-Y, Qin Z-H, Sheng R (2024) The multiple roles of autophagy in neural function and diseases. Neurosci Bull 40:363\u2013382. https:\/\/doi.org\/10.1007\/s12264-023-01120-y","journal-title":"Neurosci Bull"},{"key":"5263_CR260","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s10020-022-00489-2","volume":"28","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu Y, Yin Y et al (2022) UBE2S promotes the development of ovarian cancer by promoting PI3K\/AKT\/mTOR signaling pathway to regulate cell cycle and apoptosis. Mol Med 28:62. https:\/\/doi.org\/10.1186\/s10020-022-00489-2","journal-title":"Mol Med"},{"key":"5263_CR261","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","volume":"128","author":"X Wang","year":"2007","unstructured":"Wang X, Trotman LC, Koppie T et al (2007) NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128:129\u2013139. https:\/\/doi.org\/10.1016\/j.cell.2006.11.039","journal-title":"Cell"},{"key":"5263_CR262","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1038\/s41598-017-05510-x","volume":"7","author":"W-R Huang","year":"2017","unstructured":"Huang W-R, Chi P-I, Chiu H-C et al (2017) Avian reovirus p17 and \u03c3A act cooperatively to downregulate Akt by suppressing mTORC2 and CDK2\/cyclin A2 and upregulating proteasome PSMB6. Sci Rep 7:5226. https:\/\/doi.org\/10.1038\/s41598-017-05510-x","journal-title":"Sci Rep"},{"key":"5263_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147807","volume":"889","author":"J Jin","year":"2023","unstructured":"Jin J, He J, Li X et al (2023) The role of ubiquitination and deubiquitination in PI3K\/AKT\/mTOR pathway: a potential target for cancer therapy. Gene 889:147807. https:\/\/doi.org\/10.1016\/j.gene.2023.147807","journal-title":"Gene"},{"key":"5263_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114427","volume":"185","author":"KS Ibrahim","year":"2021","unstructured":"Ibrahim KS, McLaren CJ, Abd-Elrahman KS, Ferguson SSG (2021) Optineurin deletion disrupts metabotropic glutamate receptor 5-mediated regulation of ERK1\/2, GSK3\u03b2\/ZBTB16, mTOR\/ULK1 signaling in autophagy. Biochem Pharmacol 185:114427. https:\/\/doi.org\/10.1016\/j.bcp.2021.114427","journal-title":"Biochem Pharmacol"},{"key":"5263_CR265","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L et al (2020) The role of ubiquitination in tumorigenesis and targeted drug discovery. Sig Transduct Target Ther 5:1\u201328. https:\/\/doi.org\/10.1038\/s41392-020-0107-0","journal-title":"Sig Transduct Target Ther"},{"key":"5263_CR266","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021125","volume":"25","author":"A Longobardi","year":"2024","unstructured":"Longobardi A, Catania M, Geviti A et al (2024) Autophagy markers are altered in Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia. Int J Mol Sci 25:1125. https:\/\/doi.org\/10.3390\/ijms25021125","journal-title":"Int J Mol Sci"},{"key":"5263_CR267","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5483\/BMBRep.2021.54.12.107","volume":"54","author":"GH Park","year":"2021","unstructured":"Park GH, Park JH, Chung KC (2021) Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson\u2019s disease. BMB Rep 54:592\u2013600. https:\/\/doi.org\/10.5483\/BMBRep.2021.54.12.107","journal-title":"BMB Rep"},{"key":"5263_CR268","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-016-0141-0","volume":"11","author":"MS Wold","year":"2016","unstructured":"Wold MS, Lim J, Lachance V et al (2016) ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington\u2019s disease models. Mol Neurodegeneration 11:76. https:\/\/doi.org\/10.1186\/s13024-016-0141-0","journal-title":"Mol Neurodegeneration"},{"key":"5263_CR269","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41593-018-0076-6","volume":"21","author":"J Lisman","year":"2018","unstructured":"Lisman J, Cooper K, Sehgal M, Silva AJ (2018) Memory formation depends on both synapse-specific modifications of synaptic strength and cell-specific increases in excitability. Nat Neurosci 21:309\u2013314. https:\/\/doi.org\/10.1038\/s41593-018-0076-6","journal-title":"Nat Neurosci"},{"key":"5263_CR270","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s43440-023-00526-9","volume":"75","author":"N Khakha","year":"2023","unstructured":"Khakha N, Khan H, Kaur A, Singh TG (2023) Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration. Pharmacol Rep 75:1152\u20131165. https:\/\/doi.org\/10.1007\/s43440-023-00526-9","journal-title":"Pharmacol Rep"},{"key":"5263_CR271","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10787-024-01517-9","volume":"32","author":"G Kaur","year":"2024","unstructured":"Kaur G, Devi S, Sharma A, Sood P (2024) Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review. Inflammopharmacology 32:3057\u20133077. https:\/\/doi.org\/10.1007\/s10787-024-01517-9","journal-title":"Inflammopharmacology"},{"key":"5263_CR272","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.1073\/pnas.172504199","volume":"99","author":"OV Vitolo","year":"2002","unstructured":"Vitolo OV, Sant\u2019Angelo A, Costanzo V et al (2002) Amyloid beta -peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99:13217\u201313221. https:\/\/doi.org\/10.1073\/pnas.172504199","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR273","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02742438","volume":"20","author":"DG Chain","year":"1999","unstructured":"Chain DG, Schwartz JH, Hegde AN (1999) Ubiquitin-mediated proteolysis in learning and memory. Mol Neurobiol 20:125\u2013142. https:\/\/doi.org\/10.1007\/BF02742438","journal-title":"Mol Neurobiol"},{"key":"5263_CR274","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainresbull.2010.11.002","volume":"85","author":"D Fioravante","year":"2011","unstructured":"Fioravante D, Byrne JH (2011) Protein degradation and memory formation. Brain Res Bull 85:14\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2010.11.002","journal-title":"Brain Res Bull"},{"key":"5263_CR275","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1172\/JCI22831","volume":"114","author":"B Gong","year":"2004","unstructured":"Gong B, Vitolo OV, Trinchese F et al (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114:1624\u20131634. https:\/\/doi.org\/10.1172\/JCI22831","journal-title":"J Clin Invest"},{"key":"5263_CR276","doi-asserted-by":"publisher","first-page":"16877","DOI":"10.1073\/pnas.0908706106","volume":"106","author":"DL Smith","year":"2009","unstructured":"Smith DL, Pozueta J, Gong B et al (2009) Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc Natl Acad Sci U S A 106:16877\u201316882. https:\/\/doi.org\/10.1073\/pnas.0908706106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR277","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13311-014-0327-5","volume":"12","author":"AF Teich","year":"2015","unstructured":"Teich AF, Nicholls RE, Puzzo D et al (2015) Synaptic therapy in Alzheimer\u2019s disease: a CREB-centric approach. Neurotherapeutics 12:29\u201341. https:\/\/doi.org\/10.1007\/s13311-014-0327-5","journal-title":"Neurotherapeutics"},{"key":"5263_CR278","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1242\/jcs.03008","volume":"119","author":"A von Mikecz","year":"2006","unstructured":"von Mikecz A (2006) The nuclear ubiquitin-proteasome system. J Cell Sci 119:1977\u20131984. https:\/\/doi.org\/10.1242\/jcs.03008","journal-title":"J Cell Sci"},{"key":"5263_CR279","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.nbd.2005.05.015","volume":"20","author":"L Fu","year":"2005","unstructured":"Fu L, Gao Y, Sztul E (2005) Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Neurobiol Dis 20:656\u2013665. https:\/\/doi.org\/10.1016\/j.nbd.2005.05.015","journal-title":"Neurobiol Dis"},{"key":"5263_CR280","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00153","volume":"11","author":"C Xiang","year":"2018","unstructured":"Xiang C, Zhang S, Dong X et al (2018) Transcriptional dysregulation and post-translational modifications in polyglutamine diseases: from pathogenesis to potential therapeutic strategies. Front Mol Neurosci 11:153. https:\/\/doi.org\/10.3389\/fnmol.2018.00153","journal-title":"Front Mol Neurosci"},{"key":"5263_CR281","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","volume":"30","author":"S-Y Cong","year":"2005","unstructured":"Cong S-Y, Pepers BA, Evert BO et al (2005) Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 30:12\u201323. https:\/\/doi.org\/10.1016\/j.mcn.2005.05.003","journal-title":"Mol Cell Neurosci"},{"key":"5263_CR282","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","volume":"23","author":"H Jiang","year":"2006","unstructured":"Jiang H, Poirier MA, Liang Y et al (2006) Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol Dis 23:543\u2013551. https:\/\/doi.org\/10.1016\/j.nbd.2006.04.011","journal-title":"Neurobiol Dis"},{"key":"5263_CR283","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1383453","volume":"11","author":"M Tsekrekou","year":"2024","unstructured":"Tsekrekou M, Giannakou M, Papanikolopoulou K, Skretas G (2024) Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS. Front Mol Biosci 11:1383453. https:\/\/doi.org\/10.3389\/fmolb.2024.1383453","journal-title":"Front Mol Biosci"},{"key":"5263_CR284","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tcb.2004.10.006","volume":"14","author":"CA Ross","year":"2004","unstructured":"Ross CA, Pickart CM (2004) The ubiquitin-proteasome pathway in Parkinson\u2019s disease and other neurodegenerative diseases. Trends Cell Biol 14:703\u2013711. https:\/\/doi.org\/10.1016\/j.tcb.2004.10.006","journal-title":"Trends Cell Biol"},{"key":"5263_CR285","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tins.2017.10.002","volume":"40","author":"CA Saura","year":"2017","unstructured":"Saura CA, Cardinaux J-R (2017) Emerging roles of CREB-regulated transcription coactivators in brain physiology and pathology. Trends Neurosci 40:720\u2013733. https:\/\/doi.org\/10.1016\/j.tins.2017.10.002","journal-title":"Trends Neurosci"},{"key":"5263_CR286","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2010.12.006","volume":"336","author":"CR Jefcoate","year":"2011","unstructured":"Jefcoate CR, Lee J, Cherradi N et al (2011) cAMP stimulation of StAR expression and cholesterol metabolism is modulated by co-expression of labile suppressors of transcription and mRNA turnover. Mol Cell Endocrinol 336:53\u201362. https:\/\/doi.org\/10.1016\/j.mce.2010.12.006","journal-title":"Mol Cell Endocrinol"},{"key":"5263_CR287","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01651-w","volume":"8","author":"PD Talukdar","year":"2023","unstructured":"Talukdar PD, Chatterji U (2023) Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. Sig Transduct Target Ther 8:1\u201341. https:\/\/doi.org\/10.1038\/s41392-023-01651-w","journal-title":"Sig Transduct Target Ther"},{"key":"5263_CR288","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12987-022-00322-2","volume":"19","author":"K Devasani","year":"2022","unstructured":"Devasani K, Yao Y (2022) Expression and functions of adenylyl cyclases in the CNS. Fluids Barriers CNS 19:23. https:\/\/doi.org\/10.1186\/s12987-022-00322-2","journal-title":"Fluids Barriers CNS"},{"key":"5263_CR289","doi-asserted-by":"publisher","DOI":"10.3390\/cells12182318","volume":"12","author":"N Sanghai","year":"2023","unstructured":"Sanghai N, Tranmer GK (2023) Biochemical and molecular pathways in neurodegenerative diseases: an integrated view. Cells 12:2318. https:\/\/doi.org\/10.3390\/cells12182318","journal-title":"Cells"},{"key":"5263_CR290","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","volume":"78","author":"HJ Rideout","year":"2001","unstructured":"Rideout HJ, Larsen KE, Sulzer D, Stefanis L (2001) Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells. J Neurochem 78:899\u2013908. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00474.x","journal-title":"J Neurochem"},{"key":"5263_CR291","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2018.04.022","volume":"1691","author":"Y Zhong","year":"2018","unstructured":"Zhong Y, Chen J, Li L et al (2018) PKA-CREB-BDNF signaling pathway mediates propofol-induced long-term learning and memory impairment in hippocampus of rats. Brain Res 1691:64\u201374. https:\/\/doi.org\/10.1016\/j.brainres.2018.04.022","journal-title":"Brain Res"},{"key":"5263_CR292","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2012.08.051","volume":"527","author":"N Myeku","year":"2012","unstructured":"Myeku N, Wang H, Figueiredo-Pereira ME (2012) cAMP stimulates the ubiquitin\/proteasome pathway in rat spinal cord neurons. Neurosci Lett 527:126\u2013131. https:\/\/doi.org\/10.1016\/j.neulet.2012.08.051","journal-title":"Neurosci Lett"},{"key":"5263_CR293","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.4161\/auto.6.8.13479","volume":"6","author":"MD Houslay","year":"2010","unstructured":"Houslay MD, Christian F (2010) p62 (SQSTM1) forms part of a novel, reversible aggregate containing a specific conformer of the cAMP degrading phosphodiesterase, PDE4A4. Autophagy 6:1198\u20131200. https:\/\/doi.org\/10.4161\/auto.6.8.13479","journal-title":"Autophagy"},{"key":"5263_CR294","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s12192-018-0897-y","volume":"23","author":"L Montibeller","year":"2018","unstructured":"Montibeller L, de Belleroche J (2018) Amyotrophic lateral sclerosis (ALS) and Alzheimer\u2019s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes. Cell Stress Chaperones 23:897\u2013912. https:\/\/doi.org\/10.1007\/s12192-018-0897-y","journal-title":"Cell Stress Chaperones"},{"key":"5263_CR295","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1573407216999200723113054","volume":"17","author":"MM Alam","year":"2021","unstructured":"Alam MM, Minj E, Yadav RK, Mehan S (2021) Neuroprotective potential of adenyl cyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Curr Bioact Compd 17:53\u201369. https:\/\/doi.org\/10.2174\/1573407216999200723113054","journal-title":"Curr Bioact Compd"},{"key":"5263_CR296","doi-asserted-by":"publisher","first-page":"800","DOI":"10.4103\/1673-5374.382233","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Hu Y, Xu R (2024) The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis. Neural Regen Res 19:800. https:\/\/doi.org\/10.4103\/1673-5374.382233","journal-title":"Neural Regen Res"},{"key":"5263_CR297","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400732121","volume":"121","author":"DM Ho","year":"2024","unstructured":"Ho DM, Shaban M, Mahmood F et al (2024) cAMP\/PKA signaling regulates TDP-43 aggregation and mislocalization. Proc Natl Acad Sci 121:e2400732121. https:\/\/doi.org\/10.1073\/pnas.2400732121","journal-title":"Proc Natl Acad Sci"},{"key":"5263_CR298","doi-asserted-by":"publisher","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","volume":"112","author":"S Lokireddy","year":"2015","unstructured":"Lokireddy S, Kukushkin NV, Goldberg AL (2015) cAMP-induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci U S A 112:E7176-7185. https:\/\/doi.org\/10.1073\/pnas.1522332112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR299","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1073\/pnas.1809254116","volume":"116","author":"JJS VerPlank","year":"2019","unstructured":"VerPlank JJS, Lokireddy S, Zhao J, Goldberg AL (2019) 26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation. Proc Natl Acad Sci U S A 116:4228\u20134237. https:\/\/doi.org\/10.1073\/pnas.1809254116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5263_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116753","volume":"175","author":"L Lu","year":"2024","unstructured":"Lu L, Jifu C, Xia J, Wang J (2024) E3 ligases and DUBs target ferroptosis: a potential therapeutic strategy for neurodegenerative diseases. Biomed Pharmacother 175:116753. https:\/\/doi.org\/10.1016\/j.biopha.2024.116753","journal-title":"Biomed Pharmacother"},{"key":"5263_CR301","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307\u2013310. https:\/\/doi.org\/10.1038\/35042675","journal-title":"Nature"},{"key":"5263_CR302","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1242\/jcs.114.23.4139","volume":"114","author":"S Jin","year":"2001","unstructured":"Jin S, Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139\u20134140. https:\/\/doi.org\/10.1242\/jcs.114.23.4139","journal-title":"J Cell Sci"},{"key":"5263_CR303","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopha.2018.10.155","volume":"109","author":"A Gupta","year":"2019","unstructured":"Gupta A, Shah K, Oza MJ, Behl T (2019) Reactivation of p53 gene by MDM2 inhibitors: a novel therapy for cancer treatment. Biomed Pharmacother 109:484\u2013492. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.155","journal-title":"Biomed Pharmacother"},{"key":"5263_CR304","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1128\/MCB.23.23.8902-8912.2003","volume":"23","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Wolf GW, Bhat K et al (2003) Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23:8902\u20138912. https:\/\/doi.org\/10.1128\/MCB.23.23.8902-8912.2003","journal-title":"Mol Cell Biol"},{"key":"5263_CR305","doi-asserted-by":"publisher","first-page":"404 \u2013411","DOI":"10.1016\/j.bbcan.2017.08.001","volume":"1868","author":"S-K Kwon","year":"2017","unstructured":"Kwon S-K, Saindane M, Baek K-H (2017) p53 stability is regulated by diverse deubiquitinating enzymes. Biochimica et Biophysica Acta (BBA) - Reviews on. Cancer 1868:404\u2013411. https:\/\/doi.org\/10.1016\/j.bbcan.2017.08.001","journal-title":"Cancer"},{"key":"5263_CR306","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217207","volume":"27","author":"HG Dailah","year":"2022","unstructured":"Dailah HG (2022) Potential of therapeutic small molecules in apoptosis regulation in the treatment of neurodegenerative diseases: an updated review. Molecules 27:7207. https:\/\/doi.org\/10.3390\/molecules27217207","journal-title":"Molecules"},{"key":"5263_CR307","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13195-020-00732-0","volume":"12","author":"G Abate","year":"2020","unstructured":"Abate G, Frisoni GB, Bourdon J-C et al (2020) The pleiotropic role of p53 in functional\/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer\u2019s disease. Alz Res Therapy 12:160. https:\/\/doi.org\/10.1186\/s13195-020-00732-0","journal-title":"Alz Res Therapy"},{"key":"5263_CR308","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ncb1981","volume":"11","author":"CA da Costa","year":"2009","unstructured":"da Costa CA, Sunyach C, Giaime E et al (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson\u2019s disease. Nat Cell Biol 11:1370\u20131375. https:\/\/doi.org\/10.1038\/ncb1981","journal-title":"Nat Cell Biol"},{"key":"5263_CR309","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/onc.2010.469","volume":"30","author":"L Latonen","year":"2011","unstructured":"Latonen L, Moore HM, Bai B et al (2011) Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability. Oncogene 30:790\u2013805. https:\/\/doi.org\/10.1038\/onc.2010.469","journal-title":"Oncogene"},{"key":"5263_CR310","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","volume":"157","author":"I Buendia","year":"2016","unstructured":"Buendia I, Michalska P, Navarro E et al (2016) Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84\u2013104. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.11.003","journal-title":"Pharmacol Ther"},{"key":"5263_CR311","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107989","volume":"167","author":"S Kim","year":"2020","unstructured":"Kim S, Indu Viswanath AN, Park J-H et al (2020) Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson\u2019s disease animal model. Neuropharmacology 167:107989. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107989","journal-title":"Neuropharmacology"},{"key":"5263_CR312","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157488912803252023","volume":"7","author":"G Joshi","year":"2012","unstructured":"Joshi G, Johnson JA (2012) The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 7:218\u2013229. https:\/\/doi.org\/10.2174\/157488912803252023","journal-title":"Recent Pat CNS Drug Discov"},{"key":"5263_CR313","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00310","volume":"11","author":"SZA Shah","year":"2018","unstructured":"Shah SZA, Zhao D, Hussain T et al (2018) p62-Keap1-NRF2-ARE pathway: a contentious player for selective targeting of autophagy, oxidative stress and mitochondrial dysfunction in prion diseases. Front Mol Neurosci 11:310. https:\/\/doi.org\/10.3389\/fnmol.2018.00310","journal-title":"Front Mol Neurosci"},{"key":"5263_CR314","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cotox.2016.09.005","volume":"1","author":"Y Katsuragi","year":"2016","unstructured":"Katsuragi Y, Ichimura Y, Komatsu M (2016) Regulation of the Keap1\u2013Nrf2 pathway by p62\/SQSTM1. Current Opinion in Toxicology 1:54\u201361. https:\/\/doi.org\/10.1016\/j.cotox.2016.09.005","journal-title":"Current Opinion in Toxicology"},{"key":"5263_CR315","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1080\/15548627.2024.2384348","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Qiu Y, Yang L et al (2024) Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy. Autophagy 20:2677\u20132696. https:\/\/doi.org\/10.1080\/15548627.2024.2384348","journal-title":"Autophagy"},{"key":"5263_CR316","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s12276-021-00596-w","volume":"53","author":"P Xue","year":"2021","unstructured":"Xue P, Hu X, Chang E et al (2021) Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response. Exp Mol Med 53:667\u2013680. https:\/\/doi.org\/10.1038\/s12276-021-00596-w","journal-title":"Exp Mol Med"},{"key":"5263_CR317","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pneurobio.2012.09.003","volume":"100","author":"M Zhang","year":"2013","unstructured":"Zhang M, An C, Gao Y et al (2013) Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol 100:30\u201347. https:\/\/doi.org\/10.1016\/j.pneurobio.2012.09.003","journal-title":"Prog Neurobiol"},{"key":"5263_CR318","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020266","volume":"11","author":"C Lanzillotta","year":"2021","unstructured":"Lanzillotta C, Di Domenico F (2021) Stress responses in down syndrome neurodegeneration: state of the art and therapeutic molecules. Biomolecules 11:266. https:\/\/doi.org\/10.3390\/biom11020266","journal-title":"Biomolecules"},{"key":"5263_CR319","doi-asserted-by":"publisher","DOI":"10.3390\/biom15010113","volume":"15","author":"B Buttari","year":"2025","unstructured":"Buttari B, Tramutola A, Rojo AI et al (2025) Proteostasis decline and redox imbalance in age-related diseases: the therapeutic potential of NRF2. Biomolecules 15:113. https:\/\/doi.org\/10.3390\/biom15010113","journal-title":"Biomolecules"},{"key":"5263_CR320","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s10787-024-01549-1","volume":"32","author":"T Kaur","year":"2024","unstructured":"Kaur T, Sidana P, Kaur N et al (2024) Unraveling neuroprotection in Parkinson\u2019s disease: Nrf2\u2013Keap1 pathway\u2019s vital role amidst pathogenic pathways. Inflammopharmacol 32:2801\u20132820. https:\/\/doi.org\/10.1007\/s10787-024-01549-1","journal-title":"Inflammopharmacol"},{"key":"5263_CR321","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5288698","volume":"2022","author":"L Yan","year":"2022","unstructured":"Yan L, Guo M-S, Zhang Y et al (2022) Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities. Oxid Med Cell Longev 2022:5288698. https:\/\/doi.org\/10.1155\/2022\/5288698","journal-title":"Oxid Med Cell Longev"},{"key":"5263_CR322","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-021-00479-8","volume":"16","author":"S Bono","year":"2021","unstructured":"Bono S, Feligioni M, Corbo M (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Mol Neurodegener 16:71. https:\/\/doi.org\/10.1186\/s13024-021-00479-8","journal-title":"Mol Neurodegener"},{"key":"5263_CR323","doi-asserted-by":"publisher","DOI":"10.1038\/srep12613","volume":"5","author":"T Tomita","year":"2015","unstructured":"Tomita T, Hamazaki J, Hirayama S et al (2015) Sirt1-deficiency causes defective protein quality control. Sci Rep 5:12613. https:\/\/doi.org\/10.1038\/srep12613","journal-title":"Sci Rep"},{"key":"5263_CR324","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00614","volume":"9","author":"B Elibol","year":"2018","unstructured":"Elibol B, Kilic U (2018) High levels of SIRT1 expression as a protective mechanism against disease-related conditions. Front Endocrinol 9:614. https:\/\/doi.org\/10.3389\/fendo.2018.00614","journal-title":"Front Endocrinol"},{"key":"5263_CR325","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbagrm.2011.04.007","volume":"1809","author":"AK Pradhan","year":"2011","unstructured":"Pradhan AK, Kuila N, Singh S, Chakraborty S (2011) EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1809:269\u2013275. https:\/\/doi.org\/10.1016\/j.bbagrm.2011.04.007","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"5263_CR326","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"S-W Min","year":"2010","unstructured":"Min S-W, Cho S-H, Zhou Y et al (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67:953\u2013966. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.044","journal-title":"Neuron"},{"key":"5263_CR327","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1007\/s12035-016-0087-9","volume":"54","author":"R Corpas","year":"2017","unstructured":"Corpas R, Revilla S, Ursulet S et al (2017) SIRT1 overexpression in mouse hippocampus induces cognitive enhancement through proteostatic and neurotrophic mechanisms. Mol Neurobiol 54:5604\u20135619. https:\/\/doi.org\/10.1007\/s12035-016-0087-9","journal-title":"Mol Neurobiol"},{"key":"5263_CR328","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-170418","volume":"61","author":"X Yin","year":"2018","unstructured":"Yin X, Jiang X, Wang J et al (2018) SIRT1 deacetylates SC35 and suppresses its function in Tau exon 10 inclusion. J Alzheimers Dis 61:561\u2013570. https:\/\/doi.org\/10.3233\/JAD-170418","journal-title":"J Alzheimers Dis"},{"key":"5263_CR329","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00106","volume":"12","author":"G Kreiner","year":"2019","unstructured":"Kreiner G, S\u00f6nmez A, Liss B, Parlato R (2019) Integration of the deacetylase SIRT1 in the response to nucleolar stress: metabolic implications for neurodegenerative diseases. Front Mol Neurosci 12:106. https:\/\/doi.org\/10.3389\/fnmol.2019.00106","journal-title":"Front Mol Neurosci"},{"key":"5263_CR330","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2022) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol 20:158\u2013178. https:\/\/doi.org\/10.2174\/1570159X19666210609160017","journal-title":"Curr Neuropharmacol"},{"key":"5263_CR331","doi-asserted-by":"publisher","first-page":"794","DOI":"10.14336\/AD.2022.1123","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu H, Liu Y-Y, Li L-S, Liu Y-S (2023) Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: structure, regulation, modifications, and modulators. Aging Dis 14:794\u2013824. https:\/\/doi.org\/10.14336\/AD.2022.1123","journal-title":"Aging Dis"},{"key":"5263_CR332","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M, Wang J, Fu J et al (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18:153\u2013158. https:\/\/doi.org\/10.1038\/nm.2558","journal-title":"Nat Med"},{"key":"5263_CR333","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroscience.2022.09.021","volume":"504","author":"H Liu","year":"2022","unstructured":"Liu H, Xu S, Wang C et al (2022) The beneficial role of sirtuin 1 in preventive or therapeutic options of neurodegenerative diseases. Neuroscience 504:79\u201392. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.09.021","journal-title":"Neuroscience"},{"key":"5263_CR334","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10571-016-0452-2","volume":"37","author":"BL Tang","year":"2017","unstructured":"Tang BL (2017) Could sirtuin activities modify ALS onset and progression? Cell Mol Neurobiol 37:1147\u20131160. https:\/\/doi.org\/10.1007\/s10571-016-0452-2","journal-title":"Cell Mol Neurobiol"},{"key":"5263_CR335","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010325","volume":"19","author":"B Penke","year":"2018","unstructured":"Penke B, Bog\u00e1r F, Crul T et al (2018) Heat shock proteins and autophagy pathways in neuroprotection: from molecular bases to pharmacological interventions. Int J Mol Sci 19:325. https:\/\/doi.org\/10.3390\/ijms19010325","journal-title":"Int J Mol Sci"},{"key":"5263_CR336","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121789","volume":"13","author":"P Cilleros-Holgado","year":"2023","unstructured":"Cilleros-Holgado P, G\u00f3mez-Fern\u00e1ndez D, Pi\u00f1ero-P\u00e9rez R et al (2023) Mitochondrial quality control via mitochondrial unfolded protein response (mtUPR) in ageing and neurodegenerative diseases. Biomolecules 13:1789. https:\/\/doi.org\/10.3390\/biom13121789","journal-title":"Biomolecules"},{"key":"5263_CR337","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.147904","volume":"1786","author":"W Chen","year":"2022","unstructured":"Chen W, Guo L, Li M et al (2022) The pathogenesis of amyotrophic lateral sclerosis: mitochondrial dysfunction, protein misfolding and epigenetics. Brain Res 1786:147904. https:\/\/doi.org\/10.1016\/j.brainres.2022.147904","journal-title":"Brain Res"},{"key":"5263_CR338","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10826068.2017.1387561","volume":"48","author":"S Nusrat","year":"2018","unstructured":"Nusrat S, Khan RH (2018) Exploration of ligand-induced protein conformational alteration, aggregate formation, and its inhibition: a biophysical insight. Prep Biochem Biotechnol 48:43\u201356. https:\/\/doi.org\/10.1080\/10826068.2017.1387561","journal-title":"Prep Biochem Biotechnol"},{"key":"5263_CR339","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116777","volume":"176","author":"Z Li","year":"2024","unstructured":"Li Z, Zhang Y, Ji M et al (2024) Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics. Biomed Pharmacother 176:116777. https:\/\/doi.org\/10.1016\/j.biopha.2024.116777","journal-title":"Biomed Pharmacother"},{"key":"5263_CR340","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092488","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI et al (2023) Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities. Biomedicines 11:2488. https:\/\/doi.org\/10.3390\/biomedicines11092488","journal-title":"Biomedicines"},{"key":"5263_CR341","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","volume":"27","author":"H Bay\u0131r","year":"2020","unstructured":"Bay\u0131r H, Anthonymuthu TS, Tyurina YY et al (2020) Achieving life through death: redox biology of lipid peroxidation in ferroptosis. Cell Chem Biol 27:387\u2013408. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.014","journal-title":"Cell Chem Biol"},{"key":"5263_CR342","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J et al (2023) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97:1439\u20131451. https:\/\/doi.org\/10.1007\/s00204-023-03476-6","journal-title":"Arch Toxicol"},{"key":"5263_CR343","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10:9\u201317. https:\/\/doi.org\/10.1038\/nchembio.1416","journal-title":"Nat Chem Biol"},{"key":"5263_CR344","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis -an updated review. Mitochondrion 71:83\u201392. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","journal-title":"Mitochondrion"},{"key":"5263_CR345","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14050527","volume":"14","author":"N Abdukarimov","year":"2025","unstructured":"Abdukarimov N, Kokabi K, Kunz J (2025) Ferroptosis and iron homeostasis: molecular mechanisms and neurodegenerative disease implications. Antioxidants 14:527. https:\/\/doi.org\/10.3390\/antiox14050527","journal-title":"Antioxidants"},{"key":"5263_CR346","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M (2024) Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol 25:133\u2013155. https:\/\/doi.org\/10.1038\/s41580-023-00648-1","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5263_CR347","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.7150\/ijbs.73790","volume":"18","author":"Y Meng","year":"2022","unstructured":"Meng Y, Sun H, Li Y et al (2022) Targeting ferroptosis by ubiquitin system enzymes: a potential therapeutic strategy in cancer. Int J Biol Sci 18:5475\u20135488. https:\/\/doi.org\/10.7150\/ijbs.73790","journal-title":"Int J Biol Sci"},{"key":"5263_CR348","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12264-024-01343-7","volume":"41","author":"X Liu","year":"2025","unstructured":"Liu X, Wang W, Nie Q et al (2025) The role and mechanisms of ubiquitin-proteasome system-mediated ferroptosis in neurological disorders. Neurosci Bull 41:691\u2013706. https:\/\/doi.org\/10.1007\/s12264-024-01343-7","journal-title":"Neurosci Bull"},{"key":"5263_CR349","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060907","volume":"10","author":"M D\u00edaz","year":"2021","unstructured":"D\u00edaz M, Mesa-Herrera F, Mar\u00edn R (2021) DHA and its elaborated modulation of antioxidant defenses of the brain: implications in aging and AD neurodegeneration. Antioxidants 10:907. https:\/\/doi.org\/10.3390\/antiox10060907","journal-title":"Antioxidants"},{"key":"5263_CR350","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194852","volume":"13","author":"GR Tundo","year":"2021","unstructured":"Tundo GR, Sbardella D, Oddone F et al (2021) At the cutting edge against cancer: a perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention. Cancers 13:4852. https:\/\/doi.org\/10.3390\/cancers13194852","journal-title":"Cancers"},{"key":"5263_CR351","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1531797","volume":"12","author":"TR Church","year":"2025","unstructured":"Church TR, Margolis SS (2025) Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease. Front Cell Dev Biol 12:1531797. https:\/\/doi.org\/10.3389\/fcell.2024.1531797","journal-title":"Front Cell Dev Biol"},{"key":"5263_CR352","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.sbi.2014.02.002","volume":"24","author":"T Inobe","year":"2014","unstructured":"Inobe T, Matouschek A (2014) Paradigms of protein degradation by the proteasome. Curr Opin Struct Biol 24:156\u2013164. https:\/\/doi.org\/10.1016\/j.sbi.2014.02.002","journal-title":"Curr Opin Struct Biol"},{"key":"5263_CR353","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/biom4030862","volume":"4","author":"G Ben-Nissan","year":"2014","unstructured":"Ben-Nissan G, Sharon M (2014) Regulating the 20S proteasome ubiquitin-independent degradation pathway. Biomolecules 4:862\u2013884. https:\/\/doi.org\/10.3390\/biom4030862","journal-title":"Biomolecules"},{"key":"5263_CR354","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2024.168615","volume":"436","author":"MS Hipp","year":"2024","unstructured":"Hipp MS, Hartl FU (2024) Interplay of proteostasis capacity and protein aggregation: implications for cellular function and disease. J Mol Biol 436:168615. https:\/\/doi.org\/10.1016\/j.jmb.2024.168615","journal-title":"J Mol Biol"},{"key":"5263_CR355","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrn2286","volume":"9","author":"N Spruston","year":"2008","unstructured":"Spruston N (2008) Pyramidal neurons: dendritic structure and synaptic integration. Nat Rev Neurosci 9:206\u2013221. https:\/\/doi.org\/10.1038\/nrn2286","journal-title":"Nat Rev Neurosci"},{"key":"5263_CR356","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00264","volume":"14","author":"EN Lottes","year":"2020","unstructured":"Lottes EN, Cox DN (2020) Homeostatic roles of the proteostasis network in dendrites. Front Cell Neurosci 14:264. https:\/\/doi.org\/10.3389\/fncel.2020.00264","journal-title":"Front Cell Neurosci"},{"key":"5263_CR357","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14:457\u2013487. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x","journal-title":"J Cell Mol Med"},{"key":"5263_CR358","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091169","volume":"12","author":"A Chandran","year":"2023","unstructured":"Chandran A, Oliver HJ, Rochet J-C (2023) Role of NFE2L1 in the regulation of proteostasis: implications for aging and neurodegenerative diseases. Biology 12:1169. https:\/\/doi.org\/10.3390\/biology12091169","journal-title":"Biology"},{"key":"5263_CR359","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102819","volume":"65","author":"X Liu","year":"2023","unstructured":"Liu X, Xu C, Xiao W, Yan N (2023) Unravelling the role of NFE2L1 in stress responses and related diseases. Redox Biol 65:102819. https:\/\/doi.org\/10.1016\/j.redox.2023.102819","journal-title":"Redox Biol"},{"key":"5263_CR360","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107583","volume":"300","author":"MB Murray","year":"2024","unstructured":"Murray MB, Dixon SJ (2024) Ferroptosis regulation by Cap\u2019n\u2019collar family transcription factors. J Biol Chem 300:107583. https:\/\/doi.org\/10.1016\/j.jbc.2024.107583","journal-title":"J Biol Chem"},{"key":"5263_CR361","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aos.16661","volume":"102","author":"IS Gurubaran","year":"2024","unstructured":"Gurubaran IS (2024) Mitochondrial damage and clearance in retinal pigment epithelial cells. Acta Ophthalmol 102:3\u201353. https:\/\/doi.org\/10.1111\/aos.16661","journal-title":"Acta Ophthalmol"},{"key":"5263_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115681","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen J, Huang C, Mei J et al (2025) OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Reports 44:115681. https:\/\/doi.org\/10.1016\/j.celrep.2025.115681","journal-title":"Cell Reports"},{"key":"5263_CR363","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122906","volume":"352","author":"X Zhao","year":"2024","unstructured":"Zhao X, Xu C, Ding Y, Yan N (2024) The multifaceted functions of NFE2L1 in metabolism and associated disorders. Life Sci 352:122906. https:\/\/doi.org\/10.1016\/j.lfs.2024.122906","journal-title":"Life Sci"},{"key":"5263_CR364","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70010","volume":"5","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Le J et al (2024) Ferroptosis: mechanisms and therapeutic targets. MedComm 5:e70010. https:\/\/doi.org\/10.1002\/mco2.70010","journal-title":"MedComm"},{"key":"5263_CR365","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13070758","volume":"13","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Zhang K et al (2024) Understanding the transcription factor NFE2L1\/NRF1 from the perspective of hallmarks of cancer. Antioxidants 13:758. https:\/\/doi.org\/10.3390\/antiox13070758","journal-title":"Antioxidants"},{"key":"5263_CR366","doi-asserted-by":"publisher","DOI":"10.3390\/biology10050399","volume":"10","author":"K Iuchi","year":"2021","unstructured":"Iuchi K, Takai T, Hisatomi H (2021) Cell death via lipid peroxidation and protein aggregation diseases. Biology 10:399. https:\/\/doi.org\/10.3390\/biology10050399","journal-title":"Biology"},{"key":"5263_CR367","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1551571","volume":"18","author":"H Khodadadi","year":"2025","unstructured":"Khodadadi H, \u0141uczy\u0144ska K, Winiarczyk D et al (2025) NFE2L1 as a central regulator of proteostasis in neurodegenerative diseases: interplay with autophagy, ferroptosis, and the proteasome. Front Mol Neurosci 18:1551571. https:\/\/doi.org\/10.3389\/fnmol.2025.1551571","journal-title":"Front Mol Neurosci"},{"key":"5263_CR368","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.994037","volume":"10","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wang C, Jiang D et al (2022) New insights into the interplay between autophagy and oxidative and endoplasmic reticulum stress in neuronal cell death and survival. Front Cell Dev Biol 10:994037. https:\/\/doi.org\/10.3389\/fcell.2022.994037","journal-title":"Front Cell Dev Biol"},{"key":"5263_CR369","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040857","volume":"20","author":"L Sisinni","year":"2019","unstructured":"Sisinni L, Pietrafesa M, Lepore S et al (2019) Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int J Mol Sci 20:857. https:\/\/doi.org\/10.3390\/ijms20040857","journal-title":"Int J Mol Sci"},{"key":"5263_CR370","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2174\/1566524015666150921105453","volume":"15","author":"W-S Lee","year":"2015","unstructured":"Lee W-S, Yoo W-H, Chae H-J (2015) ER stress and autophagy. Curr Mol Med 15:735\u2013745","journal-title":"Curr Mol Med"},{"key":"5263_CR371","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2014.02.028","volume":"71","author":"A H\u00f6hn","year":"2014","unstructured":"H\u00f6hn A, Jung T, Grune T (2014) Pathophysiological importance of aggregated damaged proteins. Free Radical Biol Med 71:70\u201389. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.02.028","journal-title":"Free Radical Biol Med"},{"key":"5263_CR372","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.redox.2012.11.008","volume":"1","author":"J Zhang","year":"2013","unstructured":"Zhang J (2013) Autophagy and mitophagy in cellular damage control. Redox Biol 1:19\u201323. https:\/\/doi.org\/10.1016\/j.redox.2012.11.008","journal-title":"Redox Biol"},{"key":"5263_CR373","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/0115665232261931231006103234","volume":"24","author":"A Saleem","year":"2024","unstructured":"Saleem A, Javed M, Akhtar MF et al (2024) Current updates on the role of microRNA in the diagnosis and treatment of neurodegenerative diseases. Curr Gene Ther 24:122\u2013134. https:\/\/doi.org\/10.2174\/0115665232261931231006103234","journal-title":"Curr Gene Ther"},{"key":"5263_CR374","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060856","volume":"12","author":"M Jie","year":"2021","unstructured":"Jie M, Feng T, Huang W et al (2021) Subcellular localization of miRNAs and implications in cellular homeostasis. Genes 12:856. https:\/\/doi.org\/10.3390\/genes12060856","journal-title":"Genes"},{"key":"5263_CR375","doi-asserted-by":"publisher","first-page":"C1117","DOI":"10.1152\/ajpcell.00061.2013","volume":"304","author":"M Maurel","year":"2013","unstructured":"Maurel M, Chevet E (2013) Endoplasmic reticulum stress signaling: the microRNA connection. Am J Physiol Cell Physiol 304:C1117\u2013C1126. https:\/\/doi.org\/10.1152\/ajpcell.00061.2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"5263_CR376","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cmet.2013.06.004","volume":"18","author":"O Dumortier","year":"2013","unstructured":"Dumortier O, Hinault C, Van Obberghen E (2013) MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 18:312\u2013324. https:\/\/doi.org\/10.1016\/j.cmet.2013.06.004","journal-title":"Cell Metab"},{"key":"5263_CR377","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.parkreldis.2019.04.010","volume":"64","author":"KS Patil","year":"2019","unstructured":"Patil KS, Basak I, Dalen I et al (2019) Combinatory microRNA serum signatures as classifiers of Parkinson\u2019s disease. Parkinsonism Relat Disord 64:202\u2013210. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.010","journal-title":"Parkinsonism Relat Disord"},{"key":"5263_CR378","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuro.2017.04.007","volume":"64","author":"DS Harischandra","year":"2018","unstructured":"Harischandra DS, Ghaisas S, Rokad D et al (2018) Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson\u2019s disease: relevance to \u03b1-synuclein misfolding in metal neurotoxicity. Neurotoxicology 64:267\u2013277. https:\/\/doi.org\/10.1016\/j.neuro.2017.04.007","journal-title":"Neurotoxicology"},{"key":"5263_CR379","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101193","volume":"8","author":"N Nuzziello","year":"2019","unstructured":"Nuzziello N, Liguori M (2019) The MicroRNA centrism in the orchestration of neuroinflammation in neurodegenerative diseases. Cells 8:1193. https:\/\/doi.org\/10.3390\/cells8101193","journal-title":"Cells"},{"key":"5263_CR380","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10571-021-01093-4","volume":"42","author":"I Khan","year":"2022","unstructured":"Khan I, Preeti K, Fernandes V et al (2022) Role of microRNAs, aptamers in neuroinflammation and neurodegenerative disorders. Cell Mol Neurobiol 42:2075\u20132095. https:\/\/doi.org\/10.1007\/s10571-021-01093-4","journal-title":"Cell Mol Neurobiol"},{"key":"5263_CR381","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236055","volume":"20","author":"J Konovalova","year":"2019","unstructured":"Konovalova J, Gerasymchuk D, Parkkinen I et al (2019) Interplay between microRNAs and oxidative stress in neurodegenerative diseases. Int J Mol Sci 20:6055. https:\/\/doi.org\/10.3390\/ijms20236055","journal-title":"Int J Mol Sci"},{"key":"5263_CR382","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2025.03.006","author":"S Dhuppar","year":"2025","unstructured":"Dhuppar S, Poller WC, Murugaiyan G (2025) MicroRNAs in the biology and hallmarks of neurodegenerative diseases. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2025.03.006","journal-title":"Trends Mol Med"},{"key":"5263_CR383","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1386735","volume":"17","author":"HMH Azam","year":"2024","unstructured":"Azam HMH, R\u00f6\u00dfling RI, Geithe C et al (2024) MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review. Front Mol Neurosci 17:1386735. https:\/\/doi.org\/10.3389\/fnmol.2024.1386735","journal-title":"Front Mol Neurosci"},{"key":"5263_CR384","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102067","volume":"91","author":"FA Mir","year":"2023","unstructured":"Mir FA, Amanullah A, Jain BP et al (2023) Neuroepigenetics of ageing and neurodegeneration-associated dementia: an updated review. Ageing Res Rev 91:102067. https:\/\/doi.org\/10.1016\/j.arr.2023.102067","journal-title":"Ageing Res Rev"},{"key":"5263_CR385","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A et al (2021) Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules 26:3724. https:\/\/doi.org\/10.3390\/molecules26123724","journal-title":"Molecules"},{"key":"5263_CR386","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s11064-022-03546-8","volume":"47","author":"VK Sharma","year":"2022","unstructured":"Sharma VK, Singh TG, Prabhakar NK, Mannan A (2022) Kynurenine metabolism and Alzheimer\u2019s disease: the potential targets and approaches. Neurochem Res 47:1459\u20131476. https:\/\/doi.org\/10.1007\/s11064-022-03546-8","journal-title":"Neurochem Res"},{"key":"5263_CR387","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1021\/bi602509c","volume":"46","author":"S Zhou","year":"2007","unstructured":"Zhou S, Zhou H, Walian PJ, Jap BK (2007) Regulation of \u03b3-secretase activity in Alzheimer\u2019s disease. Biochemistry 46:2553\u20132563. https:\/\/doi.org\/10.1021\/bi602509c","journal-title":"Biochemistry"},{"key":"5263_CR388","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2018.03.004","volume":"776","author":"M Magni","year":"2018","unstructured":"Magni M, Buscemi G, Zannini L (2018) Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology. Mutation Research\/Reviews in Mutation Research 776:1\u20139. https:\/\/doi.org\/10.1016\/j.mrrev.2018.03.004","journal-title":"Mutation Research\/Reviews in Mutation Research"},{"key":"5263_CR389","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.0014-2956.2001.02633.x","volume":"269","author":"CD Syme","year":"2002","unstructured":"Syme CD, Blanch EW, Holt C et al (2002) A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. Eur J Biochem 269:148\u2013156. https:\/\/doi.org\/10.1046\/j.0014-2956.2001.02633.x","journal-title":"Eur J Biochem"},{"key":"5263_CR390","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1389450122666210707120256","volume":"23","author":"A Mannan","year":"2022","unstructured":"Mannan A, Singh TG, Singh V et al (2022) Insights into the mechanism of the therapeutic potential of herbal monoamine oxidase inhibitors in neurological diseases. Curr Drug Targets 23:286\u2013310. https:\/\/doi.org\/10.2174\/1389450122666210707120256","journal-title":"Curr Drug Targets"},{"key":"5263_CR391","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.2174\/1567205018666210218152253","volume":"17","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG (2020) CREB: a multifaceted target for Alzheimer\u2019s disease. Curr Alzheimer Res 17:1280\u20131293. https:\/\/doi.org\/10.2174\/1567205018666210218152253","journal-title":"Curr Alzheimer Res"},{"key":"5263_CR392","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbrc.2021.09.006","volume":"577","author":"M Kumar","year":"2021","unstructured":"Kumar M, Singh G, Kushwah AS et al (2021) Arbutin protects brain against middle cerebral artery occlusion-reperfusion (MCAo\/R) injury. Biochem Biophys Res Commun 577:52\u201357. https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.006","journal-title":"Biochem Biophys Res Commun"},{"key":"5263_CR393","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2015.00177","volume":"6","author":"L Rinaldi","year":"2015","unstructured":"Rinaldi L, Sepe M, Delle Donne R, Feliciello A (2015) A dynamic interface between ubiquitylation and cAMP signaling. Front Pharmacol 6:177. https:\/\/doi.org\/10.3389\/fphar.2015.00177","journal-title":"Front Pharmacol"},{"key":"5263_CR394","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40495-025-00399-x","volume":"11","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Singh TG (2025) Unveiling acid-sensing ion channels (ASICs) in neurodegeneration: implications for disease pathogenesis and therapeutic strategies. Curr Pharmacol Rep 11:19. https:\/\/doi.org\/10.1007\/s40495-025-00399-x","journal-title":"Curr Pharmacol Rep"},{"key":"5263_CR395","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11064-022-03755-1","volume":"48","author":"V Sharma","year":"2023","unstructured":"Sharma V, Singh TG, Kaur A et al (2023) Brain-derived neurotrophic factor: a novel dynamically regulated therapeutic modulator in neurological disorders. Neurochem Res 48:317\u2013339. https:\/\/doi.org\/10.1007\/s11064-022-03755-1","journal-title":"Neurochem Res"},{"key":"5263_CR396","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.70","volume":"3","author":"MJ Metcalfe","year":"2012","unstructured":"Metcalfe MJ, Huang Q, Figueiredo-Pereira ME (2012) Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis 3:e326. https:\/\/doi.org\/10.1038\/cddis.2012.70","journal-title":"Cell Death Dis"},{"key":"5263_CR397","doi-asserted-by":"publisher","first-page":"60542","DOI":"10.1007\/s11356-022-20106-3","volume":"29","author":"SK Bhargava","year":"2022","unstructured":"Bhargava SK, Singh TG, Mannan A et al (2022) Pharmacological evaluation of Thuja occidentalis for the attenuation of neuropathy via AGEs and TNF-\u03b1 inhibition in diabetic neuropathic rats. Environ Sci Pollut Res Int 29:60542\u201360557. https:\/\/doi.org\/10.1007\/s11356-022-20106-3","journal-title":"Environ Sci Pollut Res Int"},{"key":"5263_CR398","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10522-023-10045-y","volume":"24","author":"A Sharma","year":"2023","unstructured":"Sharma A, Singh AK (2023) Molecular mechanism of caloric restriction mimetics-mediated neuroprotection of age-related neurodegenerative diseases: an emerging therapeutic approach. Biogerontology 24:679\u2013708. https:\/\/doi.org\/10.1007\/s10522-023-10045-y","journal-title":"Biogerontology"},{"key":"5263_CR399","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00251","volume":"10","author":"B Kalmar","year":"2017","unstructured":"Kalmar B, Greensmith L (2017) Cellular chaperones as therapeutic targets in ALS to restore protein homeostasis and improve cellular function. Front Mol Neurosci 10:251. https:\/\/doi.org\/10.3389\/fnmol.2017.00251","journal-title":"Front Mol Neurosci"},{"key":"5263_CR400","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14498","volume":"21","author":"Q Xu","year":"2025","unstructured":"Xu Q, Liu D, Zhu L-Q et al (2025) Long non-coding RNAs as key regulators of neurodegenerative protein aggregation. Alzheimer\u2019s & Dementia 21:e14498. https:\/\/doi.org\/10.1002\/alz.14498","journal-title":"Alzheimer\u2019s & Dementia"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05263-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:13:33Z","timestamp":1761570813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05263-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":400,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5263"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05263-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The paper is submitted with the consent of all listed authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}